<SEC-DOCUMENT>0000856982-24-000050.txt : 20240521
<SEC-HEADER>0000856982-24-000050.hdr.sgml : 20240521
<ACCEPTANCE-DATETIME>20240521165224
ACCESSION NUMBER:		0000856982-24-000050
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20240515
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240521
DATE AS OF CHANGE:		20240521

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MERIT MEDICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000856982
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				870447695
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-18592
		FILM NUMBER:		24970292

	BUSINESS ADDRESS:	
		STREET 1:		1600 WEST MERIT PARK WAY
		CITY:			SOUTH JORDAN
		STATE:			UT
		ZIP:			84095
		BUSINESS PHONE:		8012531600

	MAIL ADDRESS:	
		STREET 1:		1600 WEST MERIT PARKWAY
		CITY:			SOUTH JORDAN
		STATE:			UT
		ZIP:			84095
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mmsi-20240515x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 10.6.2.5 -->
<!-- Based on: iXBRL 1.1 -->
<!-- Created on: 5/21/2024 8:50:28 PM -->
<!-- iXBRL Library version: 1.0.8826.24652 -->
<!-- iXBRL Service Job ID: abfd6b98-c396-4b9d-8797-5f44b9c298d5 -->
<html xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mmsi="http://www.meritmedical.com/20240515" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html"/><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" name="dei:EntityCentralIndexKey" id="Tc_WZODp61qgke7ZyUdlBQ-5g_2_1">0000856982</ix:nonNumeric><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" name="dei:AmendmentFlag" id="Tc_mc8a7Xc0JEG9eGYNe4lHcA_3_1">false</ix:nonNumeric><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" name="dei:CurrentFiscalYearEndDate" id="Tc_MLqsBbKuPUW0kYP_2h30UA_4_1">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" name="dei:EntityRegistrantName" id="Hidden_FyixcHKUIUaBhKYYA5rylQ">MERIT MEDICAL SYSTEMS INC</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="mmsi-20240515.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-15</xbrli:startDate><xbrli:endDate>2024-05-15</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;max-width:100%;position:relative;min-height:50.24pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1pt;padding-bottom:1pt;padding-top:1pt;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><a id="_e89782ce_c799_4122_88dc_e410decb6ea3"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:17pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:17pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Washington, D.C.&#160; 20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:17pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">FORM&#160;</b><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" name="dei:DocumentType" id="Narr_C7zgHw-GMUie7iSN6METDw"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">Pursuant to Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;">Date of Report (date of earliest event reported): </span><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="Narr_Ymz3qJnDPEKQbeEqmBBSdg"><span style="font-size:9pt;">May 15, 2024</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><img src="mmsi-20240515x8k001.jpg" alt="Graphic" style="display:inline-block;height:50.24pt;width:279.71pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:17pt;text-align:center;margin:0pt;"><span style="-sec-ix-hidden:Hidden_FyixcHKUIUaBhKYYA5rylQ;"><b style="font-family:'Times New Roman','Times','serif';font-size:17pt;font-style:normal;font-weight:bold;">Merit Medical Systems,&#160;Inc.</b></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Exact name of registrant as specified in its charter)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><a id="_482e885a_2d52_4623_b7e4_21eef4425b9e"></a><a id="Tc_lUYBk6U4dUq9Im3bvvL-Cg_2_0"></a><a id="Tc_g-XO6jBhikmVGh5FYqlzzw_2_2"></a><a id="Tc_55DL0mwGBUmhE7_ygm4yYg_2_4"></a><a id="Tc_PwmONnn1TEWDATixQWWZTw_3_0"></a><a id="Tc_PamWMT94dUmQ8ahZ7mVGZg_3_2"></a><a id="Tc_G_GQi_EyLUyPjclP6sAPng_3_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0.5pt;padding-right:0.5pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.04%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:23.6%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:33.19%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:38.04%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Tc_KrUERu-EWkuubGELXNmIaQ_1_0"><b style="font-size:9pt;font-weight:bold;">Utah</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:23.6%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" name="dei:EntityFileNumber" id="Tc_l5ze_S_uiUihTWqv9TIqpw_1_2"><b style="font-size:9pt;font-weight:bold;">0-18592</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:33.19%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" name="dei:EntityTaxIdentificationNumber" id="Tc_vXVQrSJ3BUeuMbJyPhB5eA_1_4"><b style="font-size:9pt;font-weight:bold;">87-0447695</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:38.04%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(State or other jurisdiction of</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:23.6%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Commission</p></td><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:33.19%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(I.R.S. Employer</p></td></tr><tr><td style="vertical-align:bottom;width:38.04%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">incorporation or organization)</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:23.6%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">File Number)</p></td><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:33.19%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">Identification No.)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><a id="_7d471683_06d1_45fe_9287_288340eace6c"></a><a id="Tc_M7w4vIMC4EWr5qSWind-ew_2_0"></a><a id="Tc_jN_LQfmwmUOveu7zHd9lyQ_3_0"></a><a id="Tc_1a5CFwnMq0isppQ5Yj-fzw_3_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0.5pt;padding-right:0.5pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.97%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:46.96%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.97%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" name="dei:EntityAddressAddressLine1" id="Tc_qsDn6iDGB0eHB5wiCivgnA_1_0"><b style="font-size:9pt;font-weight:bold;">1600 West Merit Parkway</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:46.96%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.97%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" name="dei:EntityAddressCityOrTown" id="Narr_-ViYoRdmV0O_n-l85UJs-w"><b style="font-size:9pt;font-weight:bold;">South Jordan</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="Narr_vVtSppVYjEmVmTmyHTLRgQ"><b style="font-size:9pt;font-weight:bold;">Utah</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:46.96%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" name="dei:EntityAddressPostalZipCode" id="Tc_OsqEW2WKXUGAJqRtl4Y7fg_2_2"><b style="font-size:9pt;font-weight:bold;">84095</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:50.97%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Address of principal executive offices)</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:46.96%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Zip Code)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:9pt;font-weight:bold;">(</b><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" name="dei:CityAreaCode" id="Narr_a9vDJzfmN0m9rQpdSQybug"><b style="font-size:9pt;font-weight:bold;">801</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" name="dei:LocalPhoneNumber" id="Narr_U4zipNAu00GXlMAFL1QIWw"><b style="font-size:9pt;font-weight:bold;">253-1600</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Registrant's telephone number, including area code)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">N/A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Former name or former address, if changed since last report)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_ejxHfFoQ1U2eegbL25gLGA"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-size:9pt;">&#160;&#160;&#160;Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr_l5l7FIusTEeQTNv0AhX9dw"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-size:9pt;">&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_CTQN0i6owEGudlQG7C9T5Q"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-size:9pt;">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_JBCpdSETd0ygk5f9UT1X5g"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-size:9pt;">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><a id="_e1adca4e_7a42_4339_9783_775404ac1f0f"></a><a id="Tc_oq5CsC_xQEaWrLBl30obPg_1_0"></a><a id="Tc_OqgTc50HSEKc6MtFZPXhag_1_2"></a><a id="Tc_Tw6jbZda80OUDCGtyFlWXw_1_4"></a><a id="Tc_b4-UmqOJyUauXHn7Ah9Idg_2_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:31.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:20.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:3.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:42.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:31.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">Title&#160;of&#160;each&#160;class</p></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:20.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">Trading&#160;Symbol(s)</p></td><td style="vertical-align:bottom;width:3.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:42.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">Name&#160;of&#160;each&#160;exchange&#160;on&#160;which&#160;registered</p></td></tr><tr><td style="vertical-align:top;width:31.7%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" name="dei:Security12bTitle" id="Tc_L_NzMt994UCPndKt8wkBVg_2_0"><span style="font-size:9pt;">Common Stock, no par value</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:2.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:20.06%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" name="dei:TradingSymbol" id="Tc_bAmLuvQnX0SqNsZAV9g9iA_2_2"><span style="font-size:9pt;">MMSI</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:3.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:42.39%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" name="dei:SecurityExchangeName" id="Narr_iah4uAQ0b06IxGAbIla6Jg"><span style="font-size:9pt;">NASDAQ</span></ix:nonNumeric><span style="font-size:9pt;"> Global Select Market System</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;">Emerging growth company&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><ix:nonNumeric contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_3ktRX-p9jk2Aihl_74Eb8w"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:3.0pt solid #000000;border-top:1px solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="display:none;line-height:0pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><a id="_08824d09_7403_4671_8f63_b65f0d528806"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Item 1.01. &#160;Entry into a Material Definitive Agreement.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On May 15, 2024, Merit Medical Systems, Inc. (&#8220;Merit&#8221;) entered into an indemnification agreement (the &#8220;Indemnification Agreement&#8221;) with Silvia M. Perez in connection with her election as a director of Merit. &#160;The Indemnification Agreement is in substantially the same form as the indemnification agreements entered into between Merit and each of its existing directors and previously filed with the U.S. Securities and Exchange Commission. &#160; &#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">In general, the Indemnification Agreement provides that Merit will indemnify Ms. Perez, to the fullest extent permitted by applicable law, against all expenses, and liabilities of any type whatsoever actually and reasonably incurred in connection with her service to, or at the request of, Merit. This indemnification is only available if she acted in good faith and in a manner she reasonably believed to be in or not opposed to the best interests of Merit, and with respect to any criminal action or proceeding, she had no reasonable cause to believe her conduct was unlawful.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">In addition and subject to certain limitations, the Indemnification Agreement provides for the advancement of expenses incurred by Ms. Perez in connection with any proceeding covered by the Indemnification Agreement. In order to obtain such advancement, she must provide Merit with an undertaking to repay all amounts if it is ultimately determined that she is not entitled to indemnification for such expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Indemnification Agreement does not exclude any other rights to indemnification or advancement of expenses to which Ms. Perez may be entitled, including any rights arising under applicable law, Merit&#8217;s articles of incorporation and bylaws, any other agreement, a vote of shareholders or resolution of directors, or otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The foregoing summary is qualified in its entirety by reference to the Indemnification Agreement, a copy of which is attached hereto as Exhibit 10.1 and is incorporated in this Item 1.01 by reference.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_497f0c96_8682_4d34_88dc_0b404053c9b3"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Item 5.02.  </b><b style="font-weight:bold;">Departure of Directors or Certain Officers; Election of Directors: Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><i style="font-style:italic;">Executive Compensation Arrangements</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-size:10pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">At Merit&#8217;s 2024 Annual Meeting of Shareholders (&#8220;Annual Meeting&#8221;) held on May 15, 2024, Merit&#8217;s shareholders approved an amendment to Merit&#8217;s 2018 Long-Term Incentive Plan (the &#8220;Incentive Plan&#8221;), to increase the number of authorized shares reserved for issuance under the Incentive Plan by 3,000,000 shares. A description of the Incentive Plan, the amendment and related matters is set forth in Merit&#8217;s definitive proxy statement on Form DEF 14A filed with the U.S. Securities and Exchange Commission on April 2, 2024 (the &#8220;Proxy Statement&#8221;) and is incorporated herein by reference. Merit&#8217;s Board of Directors (the &#8220;Board&#8221;) previously approved the amendment to the Incentive Plan, subject to receipt of shareholder approval at the Annual Meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p><a id="_a3489945_b319_4879_af9f_7d035d5a82d6"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On May 16, 2024, Merit&#8217;s Board amended and restated Merit&#8217;s Third Amended and Restated Bylaws (as so amended and restated, the &#8220;Fourth Amended and Restated Bylaws&#8221;), effective immediately. The amendments delineate the rights and responsibilities of the roles of the Chief Executive Officer and President. Previously, Fred P. Lampropoulos was acting as both President and Chief Executive Officer; however, the Board appointed Joseph C. Wright as Merit&#8217;s President on May 15, 2024, and Mr. Lampropoulos resigned from that position. Mr. Lampropoulos continues to serve as Merit&#8217;s Chief Executive Officer. The amendments principally:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</span><br/><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(i)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Revised Article II Section 2 to allow the Chief Executive Officer rather than the President to call special meetings of the shareholders;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(ii)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Revised Article III Section 4 to allow the Chief Executive Officer rather than the President to call special meetings of the Board;</span></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(iii)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Revised Article IV Section 1 to provide that the officers of Merit shall include a Chief Executive Officer;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(iv)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Revised Article IV Section 5 to specify that the Chief Executive Officer rather than the President shall, among other things, generally supervise and control Merit&#8217;s business and affairs and preside at all meetings of the shareholders and the Board; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(v)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Added a new Section 6 to Article IV stating, among other things, that the President, subject to the direction and supervision of the Chief Executive Officer, shall (i) be responsible for Merit&#8217;s operational affairs; and (ii) assist the Chief Executive Officer and perform such duties as may be assigned by the Chief Executive Officer and that the President shall, at the request of the Chief Executive Officer, or in the absence, inability or refusal to act of the Chief Executive Officer, perform the duties of the Chief Executive Officer; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:36pt;padding:0pt;">(vi)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Revised Article IV Sections 7, 8 and 9 to specify that the Vice-President, Secretary, and Treasurer shall perform the duties assigned by the Chief Executive Officer rather than the President.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The foregoing summary is qualified in its entirety by reference to the Fourth Amended and Restated Bylaws, a copy of which is attached hereto as Exhibit 3.1 and is incorporated in this Item 5.03 by reference.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p><a id="_8b3926bc_9513_41cc_8198_1a9ce61714fa"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><b style="font-weight:bold;">Item 5.07 Submission of Matters to a Vote of Security Holders.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">At the Annual Meeting, Merit&#8217;s shareholders voted on the following proposals:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;background:#ffffff;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Election of three nominees, each to serve as a director of Merit until the 2027 Annual Meeting of Shareholders and until his or her successor is duly elected and qualified;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;background:#ffffff;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Non-binding advisory proposal to approve the compensation of Merit&#8217;s named executive officers, otherwise known as a &#8220;say-on-pay&#8221; vote;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;background:#ffffff;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Approval of an amendment to increase the number of shares authorized for issuance under the Incentive Plan by 3,000,000 shares; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;background:#ffffff;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Ratification of the appointment of Deloitte &amp; Touche LLP as Merit&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2024.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;background:#ffffff;margin:0pt;"></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:102.09%;"><tr style="height:1pt;"><td style="vertical-align:middle;width:7.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:middle;width:92.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td></tr><tr style="height:1pt;"><td style="vertical-align:middle;width:7.45%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:92.54%;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:top;width:7.45%;margin:0pt;padding:0pt;"/><td style="vertical-align:top;width:92.54%;margin:0pt;padding:0pt;"/></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">A total of 58,064,556 shares of Merit&#8217;s common stock were entitled to vote at the Annual Meeting as of March 18, 2024, the record date for the Annual Meeting, of which 53,684,559 shares were represented in person or by proxy at the Annual Meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">The voting results with respect to each of the proposals are discussed further below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-style:italic;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Proposal 1 - Election of Directors</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">The votes cast for or withheld for each director nominee were as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><div style="padding-left:9pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:99.3%;"><tr style="height:12.15pt;"><td style="vertical-align:bottom;width:21.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Director Nominee</b></p></td><td style="vertical-align:bottom;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;width:18.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For</b></p></td><td style="vertical-align:bottom;width:1.29%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:18.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Against</b></p></td><td style="vertical-align:bottom;width:0.98%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:18.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Abstain</b></p></td><td style="vertical-align:bottom;width:1.07%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"/><td style="vertical-align:bottom;width:18.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Broker Non-Votes</b></p></td></tr><tr><td style="vertical-align:middle;width:21.38%;border-top:1px solid #000000;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fred P. Lampropoulos</p></td><td style="vertical-align:bottom;width:1.29%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:middle;width:18.48%;border-top:1px solid #000000;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">50,241,576</p></td><td style="vertical-align:bottom;width:1.29%;margin:0pt;padding:1.5pt;"/><td style="vertical-align:top;width:18.48%;border-top:1px solid #000000;margin:0pt;padding:1.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1,594,638</p></td><td style="vertical-align:top;width:0.98%;margin:0pt;padding:1.5pt 0pt 1.5pt 0pt;"/><td style="vertical-align:top;width:18.48%;border-top:1px solid #000000;margin:0pt;padding:1.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">19,403</p></td><td style="vertical-align:top;width:1.07%;margin:0pt;padding:1.5pt 0pt 1.5pt 0pt;"/><td style="vertical-align:top;width:18.49%;border-top:1px solid #000000;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1,828,942</p></td></tr><tr><td style="vertical-align:middle;width:21.38%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Stephen C. Evans</p></td><td style="vertical-align:bottom;width:1.29%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:middle;width:18.48%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">50,385,611</p></td><td style="vertical-align:bottom;width:1.29%;margin:0pt;padding:1.5pt;"/><td style="vertical-align:top;width:18.48%;margin:0pt;padding:1.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1,444,499</p></td><td style="vertical-align:top;width:0.98%;margin:0pt;padding:1.5pt 0pt 1.5pt 0pt;"/><td style="vertical-align:top;width:18.48%;margin:0pt;padding:1.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">25,507</p></td><td style="vertical-align:top;width:1.07%;margin:0pt;padding:1.5pt 0pt 1.5pt 0pt;"/><td style="vertical-align:middle;width:18.49%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1,828,942</p></td></tr><tr><td style="vertical-align:middle;width:21.38%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Silvia M. Perez</p></td><td style="vertical-align:bottom;width:1.29%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:middle;width:18.48%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">51,069,864</p></td><td style="vertical-align:bottom;width:1.29%;margin:0pt;padding:1.5pt;"/><td style="vertical-align:top;width:18.48%;margin:0pt;padding:1.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">707,106</p></td><td style="vertical-align:top;width:0.98%;margin:0pt;padding:1.5pt 0pt 1.5pt 0pt;"/><td style="vertical-align:top;width:18.48%;margin:0pt;padding:1.5pt 0pt 1.5pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">78,647</p></td><td style="vertical-align:top;width:1.07%;margin:0pt;padding:1.5pt 0pt 1.5pt 0pt;"/><td style="vertical-align:middle;width:18.49%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1,828,942</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">Accordingly, each of the three nominees listed above was elected to serve as a director of Merit until the 2027 Annual Meeting of Shareholders and until his or her successor is duly elected and qualified.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Proposal 2 - Advisory Vote on Executive Compensation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">The results of the voting on a non-binding advisory proposal to approve the compensation of Merit&#8217;s named executive officers were as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;max-width:100%;position:relative;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.47%;"><tr><td style="vertical-align:bottom;width:24.28%;border-bottom:1px solid #000000;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For</b></p></td><td style="vertical-align:bottom;width:1.95%;border-bottom:1px solid transparent;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;width:23.26%;border-bottom:1px solid #000000;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Against</b></p></td><td style="vertical-align:bottom;width:1.97%;border-bottom:1px solid transparent;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;width:23.27%;border-bottom:1px solid #000000;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Abstain</b></p></td><td style="vertical-align:bottom;width:1.97%;border-bottom:1px solid transparent;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;width:23.27%;border-bottom:1px solid #000000;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Broker Non-Votes</b></p></td></tr><tr><td style="vertical-align:bottom;width:24.28%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">49,962,560</p></td><td style="vertical-align:bottom;width:1.95%;margin:0pt;padding:1.5pt;"/><td style="vertical-align:bottom;width:23.26%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1,838,121</p></td><td style="vertical-align:bottom;width:1.97%;margin:0pt;padding:1.5pt;"/><td style="vertical-align:bottom;width:23.27%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">54,936</p></td><td style="vertical-align:bottom;width:1.97%;margin:0pt;padding:1.5pt;"/><td style="vertical-align:bottom;width:23.27%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1,828,942</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">Accordingly, a majority of votes cast with respect to the advisory &#8220;say-on-pay&#8221; proposal were &#8220;for&#8221; approval of the compensation of Merit&#8217;s named executive officers, as disclosed in the Proxy Statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Proposal 3 &#8211; Approval of an amendment to increase the number of shares authorized for issuance under the Incentive Plan by 3,000,000 shares</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">The results of the voting on the increase of the number of shares authorized under the Incentive Plan were as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.47%;"><tr style="height:1pt;"><td style="vertical-align:middle;width:24.28%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:1.95%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:23.26%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:1.97%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:23.27%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:1.97%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:23.27%;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:middle;width:24.28%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:1.95%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:23.26%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:1.97%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:23.27%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:1.97%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:23.27%;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:24.28%;border-bottom:1px solid #000000;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For</b></p></td><td style="vertical-align:bottom;width:1.95%;border-bottom:1px solid transparent;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;width:23.26%;border-bottom:1px solid #000000;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Against</b></p></td><td style="vertical-align:bottom;width:1.97%;border-bottom:1px solid transparent;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;width:23.27%;border-bottom:1px solid #000000;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Abstain</b></p></td><td style="vertical-align:bottom;width:1.97%;border-bottom:1px solid transparent;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;width:23.27%;border-bottom:1px solid #000000;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Broker Non-Votes</b></p></td></tr><tr><td style="vertical-align:bottom;width:24.28%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">49,916,011</p></td><td style="vertical-align:bottom;width:1.95%;margin:0pt;padding:1.5pt;"/><td style="vertical-align:bottom;width:23.26%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1,844,571</p></td><td style="vertical-align:bottom;width:1.97%;margin:0pt;padding:1.5pt;"/><td style="vertical-align:bottom;width:23.27%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">95,035</p></td><td style="vertical-align:bottom;width:1.97%;margin:0pt;padding:1.5pt;"/><td style="vertical-align:bottom;width:23.27%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1,828,942</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">Accordingly, a majority of votes cast with respect to the amendment to increase the number of shares authorized under the Incentive Plan were &#8220;for&#8221; approval.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Proposal 4 - Ratification of Appointment of Independent Registered Public Accounting Firm</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">The voting results with respect to the proposal to ratify the appointment of Deloitte &amp; Touche LLP to serve as Merit&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2024 were as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80.47%;"><tr style="height:1pt;"><td style="vertical-align:middle;width:24.28%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:1.95%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:23.26%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:1.97%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:23.27%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:1.97%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:23.27%;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:middle;width:24.28%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:1.95%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:23.26%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:1.97%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:23.27%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:1.97%;margin:0pt;padding:0pt;"/><td style="vertical-align:middle;width:23.27%;margin:0pt;padding:0pt;"/></tr><tr><td style="vertical-align:bottom;width:24.28%;border-bottom:1px solid #000000;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For</b></p></td><td style="vertical-align:bottom;width:1.95%;border-bottom:1px solid transparent;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;width:23.26%;border-bottom:1px solid #000000;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Against</b></p></td><td style="vertical-align:bottom;width:1.97%;border-bottom:1px solid transparent;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;width:23.27%;border-bottom:1px solid #000000;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Abstain</b></p></td><td style="vertical-align:bottom;width:1.97%;border-bottom:1px solid transparent;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;width:23.27%;border-bottom:1px solid #000000;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Broker Non-Votes</b></p></td></tr><tr><td style="vertical-align:bottom;width:24.28%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">51,765,374</p></td><td style="vertical-align:bottom;width:1.95%;margin:0pt;padding:1.5pt;"/><td style="vertical-align:bottom;width:23.26%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1,891,519</p></td><td style="vertical-align:bottom;width:1.97%;margin:0pt;padding:1.5pt;"/><td style="vertical-align:bottom;width:23.27%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">27,666</p></td><td style="vertical-align:bottom;width:1.97%;margin:0pt;padding:1.5pt;"/><td style="vertical-align:bottom;width:23.27%;margin:0pt;padding:1.5pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">0</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">Accordingly, Merit&#8217;s shareholders ratified the appointment of Deloitte and Touche LLP to serve as Merit&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">No other matters were submitted to a vote of shareholders at the Annual Meeting. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;background:#ffffff;margin:0pt;"><span style="margin-bottom:5pt;margin-top:5pt;visibility:hidden;">&#8203;</span></p><a id="_b16095fb_7f60_4c30_b9e0_40572d0a204a"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;">Item 8.01.  Other Events</b>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On May 16, 2024, Merit issued a press release announcing the election of Ms. Perez as a Director. &#160;A copy of that press release is attached hereto as Exhibit 99.1. The information contained in Exhibit 99.1 is intended to be furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_4d070440_9921_471a_9fd3_1a1e9c70e24f"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Item 9.01. &#160;Financial Statements and Exhibits.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Exhibits</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:15.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr style="height:34.5pt;"><td style="vertical-align:bottom;width:15.76%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">EXHIBIT&#160;NUMBER</b></p></td><td style="vertical-align:top;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;width:83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">DESCRIPTION</b></p></td></tr><tr style="height:6.8pt;"><td style="vertical-align:bottom;width:15.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">3.1</p></td><td style="vertical-align:top;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="mmsi-20240515xex3d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Fourth Amended and Restated Bylaws of Merit Medical Systems, Inc. dated May 16, 2024</span></a></p></td></tr><tr style="height:6.8pt;"><td style="vertical-align:bottom;width:15.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">10.1</p></td><td style="vertical-align:top;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="mmsi-20240515xex1d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Indemnification Agreement dated May 15, 2024 between Merit Medical Systems, Inc. and Silvia M. Perez</span></a></p></td></tr><tr style="height:14.5pt;"><td style="vertical-align:top;width:15.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">99.1</p></td><td style="vertical-align:top;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="mmsi-20240515xex99d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Press Release, dated May 16, 2024, entitled &#8220;</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Merit Medical Shareholders Elect Silvia M. Perez as New Director</span><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">&#8221;</span></a></p></td></tr><tr style="height:15.4pt;"><td style="vertical-align:top;width:15.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">104</p></td><td style="vertical-align:top;width:1.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The cover page from this Current Report on Form 8-K, formatted in Inline XBRL</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;max-width:100%;position:relative;"><a id="_db270cfa_c35d_4d0d_8197_9158b5bf4fb1"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SIGNATURES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0.5pt;padding-right:0.5pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:45.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:49.8%;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">MERIT MEDICAL SYSTEMS,&#160;INC.</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:45.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:45.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: May 21, 2024</p></td><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:45.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="text-decoration-color:#000000;">/s/ Brian G. Lloyd</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:45.7%;border-top:1px solid #000000;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Brian G. Lloyd</p></td></tr><tr><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:45.7%;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Legal Officer and Corporate Secretary</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">5</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>mmsi-20240515xex1d1.htm
<DESCRIPTION>EX-1.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.125.0--><!--Created on: 5/21/2024 08:50:27 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:8.17%;padding-right:8.17%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:right;margin:0pt;"><a name="New_Section"></a><b style="font-weight:bold;">EXHIBIT 10.1 </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">INDEMNIFICATION AGREEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>This Indemnification Agreement (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Agreement</u>&#8221;) is made as of May 15, 2024, by and between Merit Medical Systems, Inc., a Utah corporation (&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Company</u>&#8221;), and Silvia M. Perez, an individual (&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Indemnitee</u>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">RECITALS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">A.</font>The Company is aware that because of the increased exposure to litigation costs, talented and experienced persons are increasingly reluctant to serve or continue serving as directors and officers of corporations unless they are protected by comprehensive liability insurance and indemnification.</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">B.</font>The statutes and judicial decisions regarding the duties of directors and officers are often difficult to apply, ambiguous, or conflicting, and therefore often fail to provide such directors and officers with adequate guidance regarding the proper course of action.</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">C.</font>The Board of Directors of the Company (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Board</u>&#8221;), has concluded that, in order to retain and attract talented and experienced individuals to serve as officers and directors of the Company and its subsidiaries and to encourage such individuals to take the business risks necessary for the success of the Company and its subsidiaries, the Company should contractually indemnify its officers and directors, and the officers and directors of its subsidiaries, in connection with claims against such officers and directors relating to their services to the Company and its subsidiaries and has further concluded that the failure to provide such contractual indemnification could be detrimental to the Company, its subsidiaries and shareholders.<font style="display:inline-block;width:5.12pt;"></font></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">D.</font>Indemnitee&#8217;s willingness to serve as a director of the Company is predicated, in substantial part, upon the Company&#8217;s willingness to indemnify Indemnitee in accordance with the principles reflected above, to the fullest extent permitted by the laws of the State of Utah, and upon the other undertakings set forth in this Agreement.</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">AGREEMENT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>NOW, THEREFORE, in consideration of the mutual promises made in this Agreement, and for other good and valuable consideration, the receipt and legal sufficiency of which is hereby acknowledged, the Company and Indemnitee, intending to be legally bound hereby, hereby agree as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.</font></font><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Definitions</b>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">(a)</font><b style="font-weight:bold;">Agent</b>. &#160;&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Agent</u>&#8221; with respect to the Company means any person who is or was a director, officer, employee or other agent of the Company or a subsidiary; or is or was serving at the request of, for the convenience of, or to represent the interests of, the Company or a subsidiary as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise (including without limitation any employee benefit plan whether or not subject to the Employee Retirement Income Security Act of 1974, as amended (&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">ERISA</u>&#8221;)); or was a director, officer, employee or agent of a predecessor corporation (or other predecessor entity or enterprise) of the Company or a subsidiary, or was a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise (including without limitation any employee benefit plan whether or not subject to the ERISA) at the request of, for the convenience of, or to represent the interests of such predecessor.</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">(b)</font><b style="font-weight:bold;">Change in Control</b>. &#160;&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Change in Control</u>&#8221; shall mean, and shall be deemed to have occurred if, on or after the date of this Agreement: &#160;(i)&#160;any &#8220;person&#8221; (as such term is used in Sections&#160;13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) or group acting in concert, other than a trustee or other fiduciary holding securities under an employee benefit plan of the Company acting in such capacity or a corporation owned directly or indirectly by </div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.17%;margin-right:8.17%;margin-top:30pt;page-break-after:always;width:83.66%;border-width:0;"><div style="max-width:100%;padding-left:8.17%;padding-right:8.17%;position:relative;"><div style="margin-top:8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><font style="color:#ff0000;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:0pt;">the shareholders of the Company in substantially the same proportions as their ownership of stock of the Company, becomes the &#8220;beneficial owner&#8221; (as defined in Rule&#160;13d-3 under said Act), directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the total voting power represented by the Company&#8217;s then outstanding voting securities; (ii)&#160;during any period of two (2) consecutive years, individuals who at the beginning of such period constitute the Board and any new director whose election by the Board or nomination for election by the Company&#8217;s shareholders was approved by a vote of at least two-thirds (2/3) of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute a majority thereof; (iii) the shareholders of the Company approve a merger or consolidation of the Company with any other corporation other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least eighty percent (80%) of the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; or (iv) the shareholders of the Company approve a plan of complete liquidation of the Company or an agreement for the sale or disposition by the Company of (in one transaction or a series of related transactions) all or substantially all of the Company&#8217;s assets.</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">(c)</font><b style="font-weight:bold;">Company</b>. &#160;References to the &#8220;Company&#8221; shall include, in addition to Merit Medical Systems, Inc., any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger to which Merit Medical Systems, Inc. (or any of its wholly-owned subsidiaries) is a party which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, employees, agents or fiduciaries, so that if Indemnitee is or was a director, officer, employee, agent or fiduciary of such constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee, agent or fiduciary of another corporation, partnership, joint venture, employee benefit plan, trust or other enterprise, Indemnitee shall stand in the same position under the provisions of this Agreement with respect to the resulting or surviving corporation as Indemnitee would have with respect to such constituent corporation if its separate existence had continued.</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">(d)</font><b style="font-weight:bold;">Expenses</b>. &#160;&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Expenses</u>&#8221; means all direct and indirect costs of any type or nature whatsoever (including, without limitation, all reasonable attorneys&#8217; and experts&#8217; fees, costs of investigation and related disbursements) reasonably incurred by Indemnitee in connection with the investigation (whether formal or informal), settlement, defense or appeal of a Proceeding covered hereby or the establishment or enforcement of a right to indemnification under this Agreement, including without limitation in the case of an appeal the premium for, and other costs relating to, any costs bond or supersedeas bond or other appeal bond or its equivalent.</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">(e)</font><b style="font-weight:bold;">Independent Legal Counsel</b>. &#160;&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Independent Legal Counsel</u>&#8221; shall mean an attorney or firm of attorneys, selected in accordance with the provisions of Section&#160;2(i) hereof, who shall not have otherwise performed services for the Company or Indemnitee within the preceding three years (other than with respect to matters concerning the rights of Indemnitee under this Agreement, or of other Indemnitees under similar indemnity agreements).</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">(f)</font><b style="font-weight:bold;">Other References</b>. &#160;References to &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">other enterprises</u>&#8221; shall include employee benefit plans; references to &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">fines</u>&#8221; shall include any excise taxes assessed on Indemnitee with respect to an employee benefit plan; and references to &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">serving at the request of the Company</u>&#8221; shall include any service as a director, officer, employee, agent or fiduciary of the Company which imposes duties on, or involves services by, such director, officer, employee, agent or fiduciary with respect to an employee benefit plan, its participants or its beneficiaries; and if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan, Indemnitee shall be deemed to have acted in a manner &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">not opposed to the best interests of the Company</u>&#8221; as referred to in this Agreement.</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">(g)</font><b style="font-weight:bold;">Proceeding</b>. &#160;&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Proceeding</u>&#8221; means any threatened, pending, or completed claim, suit, action, proceeding or alternative dispute resolution mechanism, or any hearing or investigation, whether civil, criminal, administrative, investigative or otherwise, including without limitation any situation which Indemnitee believes in good faith might lead to the institution of any such proceeding.</div></div><div style="clear:both;display:table;margin-bottom:23pt;min-height:20pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;">2</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.17%;margin-right:8.17%;margin-top:30pt;page-break-after:always;width:83.66%;border-width:0;"><div style="max-width:100%;padding-left:8.17%;padding-right:8.17%;position:relative;"><div style="margin-top:8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><font style="color:#ff0000;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">(h)</font><b style="font-weight:bold;">Reviewing Party</b>. &#160;&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reviewing Party</u>&#8221; shall mean, subject to the provisions of Section 2(g), any person or body appointed by the Board in accordance with applicable law to review the Company&#8217;s obligations hereunder and under applicable law, which may include a member or members of the Board, Independent Legal Counsel or any other person or body not a party to the particular Proceeding for which Indemnitee is seeking indemnification, as set forth in Section 2(i).</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.</font></font><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Indemnification</b>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(a)<font style="display:inline-block;width:24.9pt;"></font><b style="font-weight:bold;">Third Party Proceedings</b>. &#160;The Company shall defend, indemnify and hold harmless Indemnitee to the fullest extent permitted by the Utah Revised Business Corporation Act (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Act</u>&#8221;) if Indemnitee is or was a party or is threatened to be made a party to any Proceeding (other than an action by or in the right of the Company) by reason of the fact that Indemnitee is or was or is claimed to be an Agent of the Company, any subsidiary of the Company or any committee or subcommittee of the Board, by reason of any action or inaction on the part of Indemnitee while an Agent of the Company, against all Expenses and liabilities of any type whatsoever (including, but not limited to, judgments, fines, ERISA excise taxes or penalties, and amounts paid in settlement (if such settlement is approved in advance by the Company, which approval shall not be unreasonably withheld)) &#160;actually and reasonably incurred by Indemnitee in connection with such Proceeding if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company, and, with respect to any criminal action or proceeding, had no reasonable cause to believe Indemnitee&#8217;s conduct was unlawful.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(b)<font style="display:inline-block;width:24.34pt;"></font><b style="font-weight:bold;">Proceedings By or in the Right of the Company</b>. &#160;The Company shall defend, indemnify and hold harmless Indemnitee to the fullest extent permitted by the Act if Indemnitee was or is a party or is threatened to be made a party to any Proceeding by or in the right of the Company or any subsidiary of the Company to procure a judgment in its favor by reason of the fact that Indemnitee is or was or is claimed to be an Agent of the Company, all Expenses and liabilities of any type whatsoever (including, but not limited to, legal fees, judgments, fines, ERISA excise taxes or penalties, and amounts paid in settlement (if such settlement is approved in advance by the Company, which approval shall not be unreasonably withheld)), in each case to the extent actually and reasonably incurred by Indemnitee in connection with the defense or settlement of such Proceeding if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company and its stockholders, except that no indemnification shall be made in respect of any claim, issue or matter as to which Indemnitee shall have been finally adjudicated by court order or judgment to be liable to the Company in the performance of Indemnitee&#8217;s duty to the Company and its stockholders unless and only to the extent that the court in which such action or proceeding is or was pending shall determine upon application that, in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnity for such expenses, which such court shall deem proper.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(c)<font style="display:inline-block;width:24.9pt;"></font><b style="font-weight:bold;">Presumptions; Burden of Proof</b>. &#160;In making any determination concerning Indemnitee&#8217;s right to indemnification, there shall be a presumption that Indemnitee has satisfied the applicable standard of conduct, and the Company may overcome such presumption only by its adducing clear and convincing evidence to the contrary. &#160;For purposes of this Agreement, the termination of any Proceeding by judgment, order, settlement (whether with or without court approval) or conviction, or upon a plea of nolo contendere, or its equivalent, shall not create a presumption that Indemnitee did not meet any particular standard of conduct or have any particular belief or that a court has determined that indemnification is not permitted by this Agreement or applicable law. &#160;In addition, neither the failure of any Reviewing Party to have made a determination as to whether Indemnitee has met any particular standard of conduct or had any particular belief, nor an actual determination by any Reviewing Party that Indemnitee has not met such standard of conduct or did not have such belief, prior to the commencement of legal proceedings by Indemnitee to secure a judicial determination that Indemnitee should be indemnified under this Agreement under applicable law, shall be a defense to Indemnitee&#8217;s claim or create a presumption that Indemnitee has not met any particular standard of conduct or did not have any particular belief. &#160;Any determination concerning Indemnitee&#8217;s right to indemnification that is adverse to Indemnitee may be challenged by Indemnitee in the courts of the State of Utah. &#160;No determination by the Company (including without limitation by its directors or any Independent Legal Counsel) that Indemnitee has not satisfied any applicable standard of conduct shall be a defense to any claim by Indemnitee for indemnification or reimbursement or advance payment of Expenses by the Company hereunder or create a presumption that Indemnitee has not met any applicable standard of conduct.</p></div><div style="clear:both;display:table;margin-bottom:23pt;min-height:20pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;">3</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.17%;margin-right:8.17%;margin-top:30pt;page-break-after:always;width:83.66%;border-width:0;"><div style="max-width:100%;padding-left:8.17%;padding-right:8.17%;position:relative;"><div style="margin-top:8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><font style="color:#ff0000;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(d)</font></font><b style="font-weight:bold;">Reliance as a Safe Harbor</b>. &#160;For purposes of this Agreement, and without creating any presumption as to a lack of good faith if the following circumstances do not exist, Indemnitee shall be deemed to have acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company if Indemnitee&#8217;s actions or omissions to act are taken in good faith reliance upon the records of the Company, including its financial statements, or upon information, opinions, reports or statements furnished to Indemnitee by other Agents of the Company or any of its subsidiaries in the course of their duties, or by committees of the Board or by any other person (including legal counsel, accountants and financial advisors) as to matters Indemnitee reasonably believes are within such other person&#8217;s professional or expert competence and who has been selected with reasonable care by or on behalf of the Company. In addition, the knowledge and/or actions, or failures to act, of any Agent of the Company shall not be imputed to Indemnitee for purposes of determining the right to indemnity hereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(e)</font></font><b style="font-weight:bold;">Actions Where Indemnitee Is Deceased</b>. &#160;If Indemnitee was or is a party, or is threatened to be made a party, to any Proceeding by reason of the fact that Indemnitee is or was an Agent of the Company, or by reason of anything done or not done by Indemnitee in any such capacity, and prior to, during the pendency of, or after completion of, such Proceeding, Indemnitee shall die, then the Company shall defend, indemnify and hold harmless the estate, heirs and legatees of Indemnitee against any and all Expenses and liabilities reasonably incurred by or for such persons or entities in connection with the investigation, defense, settlement or appeal of such Proceeding on the same basis as provided for Indemnitee in Sections&#160;2(a) and 2(b) above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(f)</font></font><b style="font-weight:bold;">Extent of Insurance</b>. &#160;The Expenses and liabilities covered hereby shall be net of any payments made irrevocably to or on behalf of Indemnitee by any D&amp;O Insurance carriers or others and, for the avoidance of doubt, the Company will not be liable for the payment of any Expenses or liabilities for which Indemnitee has received payment from a D&amp;O Insurance carrier or other person unless and until the D&amp;O Insurance Carrier or such other person requests reimbursement of such Expenses or liabilities from Indemnitee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(g)</font></font><b style="font-weight:bold;">Review of Indemnification Obligations</b>. &#160;Notwithstanding the foregoing, in the event any Reviewing Party shall have determined (in a written opinion, in any case in which Independent Legal Counsel is the Reviewing Party) that Indemnitee is not entitled to be indemnified hereunder under applicable law: &#160;(i) the Company shall have no further obligation under Section&#160;2(a) or Section 2(b) to make any payments to Indemnitee not made prior to such determination by such Reviewing Party; and (ii) the Company shall be entitled to be reimbursed by Indemnitee (who hereby agrees to reimburse the Company) for all Expenses theretofore paid to Indemnitee to which Indemnitee is not entitled hereunder under applicable law; <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u>, <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">however</u>, that if Indemnitee has commenced or thereafter commences legal proceedings in a court of competent jurisdiction to secure a determination that Indemnitee is entitled to be indemnified hereunder under applicable law, any determination made by any Reviewing Party that Indemnitee is not entitled to be indemnified hereunder under applicable law shall not be binding and Indemnitee shall not be required to reimburse the Company for any Expenses theretofore paid in indemnifying Indemnitee until a final judicial determination is made with respect thereto (as to which all rights of appeal therefrom have been exhausted or lapsed). &#160;Indemnitee&#8217;s obligation to reimburse the Company for any Expenses shall be unsecured and no interest shall be charged thereon.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(h)</font></font><b style="font-weight:bold;">Indemnitee Rights on Unfavorable Determination; Binding Effect</b>. &#160;If any Reviewing Party determines that Indemnitee substantively is not entitled to be indemnified hereunder in whole or in part under applicable law, Indemnitee shall have the right to commence litigation seeking an initial determination by the court or challenging any such determination by such Reviewing Party or any aspect thereof, including the legal or factual bases therefor, and the Company hereby consents to service of process and to appear in any such proceeding. &#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</font></font><b style="font-weight:bold;">Selection of Reviewing Party; Change in Control</b>. &#160;A determination, if required by applicable law, with respect to Indemnitee&#8217;s entitlement to indemnification shall be made in accordance with the provisions of this paragraph&#160;(i). &#160;If there has not been a Change in Control, a Reviewing Party shall be selected by the Board, and if there has been such a Change in Control (other than a Change in Control which has been approved by a majority of the Board who were directors immediately prior to such Change in Control), any Reviewing Party with respect to all matters thereafter arising concerning the rights of </p></div><div style="clear:both;display:table;margin-bottom:23pt;min-height:20pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;">4</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.17%;margin-right:8.17%;margin-top:30pt;page-break-after:always;width:83.66%;border-width:0;"><div style="max-width:100%;padding-left:8.17%;padding-right:8.17%;position:relative;"><div style="margin-top:8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><font style="color:#ff0000;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;">Indemnitee to indemnification of Expenses under this Agreement or any other agreement or under the Company&#8217;s Articles of Incorporation or Bylaws as now or hereafter in effect, or under any other applicable law, if desired by Indemnitee, shall be Independent Legal Counsel selected by Indemnitee and approved by the Company (which approval shall not be unreasonably withheld, conditioned or delayed). &#160;Such counsel, among other things, shall render its written opinion to the Company and Indemnitee as to whether and to what extent Indemnitee would be entitled to be indemnified hereunder under applicable law and the Company agrees to abide by such opinion. &#160;The Company agrees to pay the reasonable fees of the Independent Legal Counsel referred to above and to indemnify fully such counsel against any and all expenses (including attorneys&#8217; fees), claims, liabilities and damages arising out of or relating to this Agreement or its engagement pursuant hereto. &#160;Notwithstanding any other provision of this Agreement, the Company shall not be required to pay Expenses of more than one Independent Legal Counsel in connection with all matters concerning a single Indemnitee (other than to the extent local counsel or counsel with particular expertise are required), and such Independent Legal Counsel shall be the Independent Legal Counsel for any or all other Indemnitees unless: &#160;(i) the employment of separate counsel by one or more Indemnitees has been previously authorized by the Board in writing; or (ii) an Indemnitee shall have provided to the Company a written statement that such Indemnitee has reasonably concluded that there may be a conflict of interest between such Indemnitee and the other Indemnitees with respect to the matters arising under this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt 0pt 0pt 9pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3. &#160; </font></font><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Expenses; Indemnification Procedure</b>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(a)<font style="display:inline-block;width:24.9pt;"></font><b style="font-weight:bold;">Advancement of Expenses</b>. &#160;The Company shall advance all expenses incurred by Indemnitee in connection with the investigation, defense, settlement or appeal of any civil or Proceeding referred to in Section 2(a) or Section 2(b) hereof (including amounts actually paid in settlement of any such Proceeding if such settlement is approved in advance by the Company, which approval shall not be unreasonably withheld, conditioned or delayed). &#160;Indemnitee hereby undertakes to repay such amounts advanced only if, and to the extent that, it shall ultimately be determined by a court of competent jurisdiction in a final judgment, not subject to appeal, that Indemnitee is not entitled to be indemnified by the Company as authorized hereby.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt 0pt 0pt 81pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(b)<font style="display:inline-block;width:24.34pt;"></font><b style="font-weight:bold;">Notice/Cooperation by Indemnitee</b>. &#160;Promptly after receipt by Indemnitee of notice of the commencement or threat of any Proceeding covered hereby, Indemnitee shall (to the extent legally permitted) notify the Company of the commencement or threat thereof, provided that any failure to so notify shall not relieve the Company of any of its obligations hereunder. &#160;Notice to the Company shall be directed to the Chief Executive Officer of the Company and the Chief Legal Officer of the Company, and shall be given in accordance with the provisions of Section 12(i) below. &#160;In addition, Indemnitee shall give the Company such information and cooperation as it may reasonably require and as shall be within Indemnitee&#8217;s power.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(c)<font style="display:inline-block;width:24.9pt;"></font><b style="font-weight:bold;">Notice to Insurers</b>. &#160;If, at the time of the receipt of a notice of a claim pursuant to Section 3(b) hereof, the Company has D&amp;O Insurance (as defined in Section 6(a) below) in effect, the Company shall give prompt notice of the commencement of such proceeding to the insurers in accordance with the procedures set forth in the respective policies. &#160;The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of the Indemnitee, all amounts payable as a result of such proceeding in accordance with the terms of such policies, including any advancement of expenses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(d) <font style="display:inline-block;width:21.84pt;"></font> Indemnitee shall be entitled to retain one or more counsel from time to time selected by Indemnitee in Indemnitee&#8217;s reasonable discretion to act as its counsel in and for the investigation, defense, settlement or appeal of each Proceeding. &#160;The Company shall not waive any privilege or right available to Indemnitee in any such Proceeding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(e)<font style="display:inline-block;width:24.9pt;"></font>The Company shall bear all reasonable fees and Expenses (including invoices for advance retainers) of such counsel, and all reasonable fees and Expenses invoiced by other persons or entities, in connection with the investigation, defense, settlement or appeal of each such Proceeding. &#160;Such fees and Expenses are referred to herein as &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Covered Expenses</u>.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(f)<font style="display:inline-block;width:26.01pt;"></font>Until a determination to the contrary under Section 4 hereof is made, the Company shall advance all Covered Expenses in connection with each Proceeding. &#160;Indemnitee shall qualify for advances upon the execution and delivery to the Company of this Agreement which shall constitute an undertaking providing that Indemnitee undertakes to the extent required by law to repay the advance if and to the extent that it is ultimately determined by a court of competent jurisdiction in a final </p></div><div style="clear:both;display:table;margin-bottom:23pt;min-height:20pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;">5</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.17%;margin-right:8.17%;margin-top:30pt;page-break-after:always;width:83.66%;border-width:0;"><div style="max-width:100%;padding-left:8.17%;padding-right:8.17%;position:relative;"><div style="margin-top:8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><font style="color:#ff0000;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;">judgment, not subject to appeal, that Indemnitee is not entitled to be indemnified by the Company. &#160;No other form of undertaking shall be required other than the execution of this Agreement. &#160;Advances shall be unsecured and interest free. &#160;Advances shall be made without regard to Indemnitee&#8217;s ability to repay the expenses and without regard to Indemnitee&#8217;s ultimate entitlement to indemnification under the other provisions of this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(g)<font style="display:inline-block;width:24.34pt;"></font><b style="font-weight:bold;">Selection of Counsel</b>. &#160;In the event the Company shall be obligated hereunder to provide indemnification for and/or make any advancement of Expenses with respect to the Expenses of any Proceeding, the Company, if appropriate, shall be entitled to assume the defense of such Proceeding with counsel selected by the Company, subject to approval by Indemnitee (which approval shall not be unreasonably withheld), upon the delivery to Indemnitee of written notice of the Company&#8217;s election to do so. &#160;After delivery of such notice and the retention of such counsel by the Company, the Company will not be liable to Indemnitee under this Agreement for any fees or expenses of separate counsel subsequently retained by or on behalf of Indemnitee with respect to the same Proceeding; provided that: &#160;(i)&#160;Indemnitee shall have the right to employ Indemnitee&#8217;s separate counsel in any such Proceeding at Indemnitee&#8217;s expense; and (ii)&#160;if (A)&#160;the employment of separate counsel by Indemnitee has been previously authorized by the Company, (B)&#160;Indemnitee shall have reasonably concluded that there may be a conflict of interest between the Company and Indemnitee in the conduct of any such defense, or (C)&#160;the Company shall not continue to retain such counsel to defend such Proceeding, then the fees and expenses of Indemnitee&#8217;s separate counsel shall be Expenses for which Indemnitee may receive indemnification or advancement of Expenses hereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(h)</font></font>Each advance to be made hereunder shall be paid by the Company to Indemnitee within ten (10) business days following delivery of a written request therefor by Indemnitee to the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">(a)</font>The Company acknowledges the potentially severe damage to Indemnitee should the Company fail timely to make such advances to Indemnitee.</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">(b)</font>The Company shall not settle any Proceeding if, as a result of such settlement, any fine or obligation is imposed on Indemnitee without Indemnitee&#8217;s prior written consent.</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.</font></font><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Determination of Right to Indemnification</b>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">(a)</font>To the extent Indemnitee has been successful on the merits or otherwise in defense of any Proceeding, claim, issue or matter covered hereby, Indemnitee need not repay any of the Expenses advanced in connection with the investigation, defense or appeal of such Proceeding.</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">(b)</font>Indemnitee shall have the right to advancement by the Company prior to the final disposition of any Proceeding of any and all Expenses relating to, arising out of or resulting from any Proceeding paid or incurred by Indemnitee or which Indemnitee determines are reasonably likely to be paid or incurred by Indemnitee.</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">(c)</font>Subject to the provisions of Section&#160;2(g), notwithstanding a determination by a Reviewing Party or a court that Indemnitee is not entitled to indemnification with respect to a specific Proceeding, Indemnitee shall have the right to apply to the courts of the State of Utah for the purpose of enforcing Indemnitee&#8217;s right to indemnification pursuant to this Agreement.</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">(d)</font>Subject to the provisions of Section&#160;2(i), &#160;the Company shall indemnify Indemnitee against all Expenses reasonably incurred by Indemnitee in connection with any Proceeding under Sections 4(b) or 4(c) and against all Expenses reasonably incurred by Indemnitee in connection with any other Proceeding between the Company and Indemnitee involving the interpretation or enforcement of the rights of Indemnitee under this Agreement unless a court of competent jurisdiction finds that each of the material claims and/or defenses of Indemnitee in any such Proceeding were frivolous or made in bad faith.</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">(e)</font>The Company hereby agrees to indemnify Indemnitee to the fullest extent permitted by the Act, notwithstanding that such indemnification is not specifically authorized by the other provisions of this Agreement, the </div></div><div style="clear:both;display:table;margin-bottom:23pt;min-height:20pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;">6</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.17%;margin-right:8.17%;margin-top:30pt;page-break-after:always;width:83.66%;border-width:0;"><div style="max-width:100%;padding-left:8.17%;padding-right:8.17%;position:relative;"><div style="margin-top:8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><font style="color:#ff0000;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:0pt;">Company&#8217;s Articles of Incorporation, the Company&#8217;s Bylaws or by statute. &#160;In the event of any change after the date of this Agreement to the Act or in any applicable law, statute or rule which expands the right of a Utah corporation to indemnify a member of its board of directors or an officer, employee, agent or fiduciary, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits afforded by such change. &#160;In the event of any change to the Act or in any applicable law, statute or rule which narrows the right of a Utah corporation to indemnify its Agent, such change, to the extent not otherwise required by the Act or such law, statute or rule to be applied to this Agreement, shall have no effect on this Agreement or the parties&#8217; rights and obligations hereunder except as set forth in Section&#160;8 hereof.</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">(f)</font><b style="font-weight:bold;">Nonexclusivity</b>. &#160;The indemnification and the payment of Expense advances provided by this Agreement shall be in addition to any rights to which Indemnitee may be entitled under the Company&#8217;s Articles of Incorporation, its Bylaws, any other agreement, any vote of shareholders or disinterested directors, the Act, or otherwise. &#160;The indemnification and the payment or advancement of Expenses provided under this Agreement shall continue as to Indemnitee for any action taken or not taken while serving in an indemnified capacity even though subsequent thereto Indemnitee may have ceased to serve in such capacity.</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">(g)</font><b style="font-weight:bold;">No Duplication of Payments</b>. &#160;The Company shall not be liable under this Agreement to make any payment in connection with any Proceeding to the extent Indemnitee has otherwise actually received payment (under any insurance policy, provision of the Company&#8217;s Articles of Incorporation, Bylaws or otherwise) of the amounts otherwise payable hereunder.</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-left:36pt;margin-top:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-indent:0pt;white-space:nowrap;">(h)</font><b style="font-weight:bold;">Partial Indemnification</b>. &#160;If Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for some or a portion of Expenses incurred in connection with any Proceeding, but not, however, for all of the total amount thereof, the Company shall nevertheless indemnify Indemnitee for the portion of such Expenses to which Indemnitee is entitled.</div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">5. &#160;</font></font><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Mutual Acknowledgement</b>. &#160;Both the Company and Indemnitee acknowledge that in certain instances, Federal law or public policy may override applicable state law and prohibit the Company from indemnifying its directors and officers under this Agreement or otherwise. &#160;For example, the Company and Indemnitee acknowledge that the Securities and Exchange Commission (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">SEC</u>&#8221;) has taken the position that indemnification is not permissible for liabilities arising under certain federal securities laws, and federal legislation prohibits indemnification for certain ERISA violations. &#160;Indemnitee understands and acknowledges that the Company has undertaken or may be required in the future to undertake with the SEC to submit the question of indemnification to a court in certain circumstances for a determination of the Company&#8217;s right under public policy to indemnify Indemnitee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">6. &#160;</font></font><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Officer and Director Liability Insurance</b>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(a)<font style="display:inline-block;width:24.9pt;"></font>The Company hereby covenants and agrees with Indemnitee that, subject to Section 6(b), the Company shall obtain and maintain in full force and effect directors&#8217; and officers&#8217; liability insurance (&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">D&amp;O Insurance</u>&#8221;), in reasonable amounts as the Board shall determine from established and reputable insurers with an AM Best rating of A.VI or better, but no less than the amounts in effect upon initial procurement of the D&amp;O Insurance. &#160;In all policies of D&amp;O Insurance, Indemnitee shall be named as an insured.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(b)<font style="display:inline-block;width:24.34pt;"></font>Notwithstanding the foregoing, the Company shall have no obligation to obtain or maintain D&amp;O Insurance if the Board determines in good faith that the premium costs for such insurance are (i) disproportionate to the amount of coverage provided after giving effect to exclusions, and (ii) substantially more burdensome to the Company than the premiums charged to the Company for its initial D&amp;O Insurance; <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u> that Indemnitee is given written notice of any such determination within thirty (30) days of the date that it is made (but in no event shall such notice be given less than ten (10) days prior to the termination of any existing D&amp;O Insurance); <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">provided</u>, <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">further</u>, that the Company will be required to obtain and maintain &#8220;tail&#8221; insurance policies covering Indemnitee for any act or omission taken prior to the termination of the D&amp;O Insurance. For the avoidance of doubt, the Company shall still be obligated to provide indemnification for and/or make any advancement of Expenses with respect </p></div><div style="clear:both;display:table;margin-bottom:23pt;min-height:20pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;">7</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.17%;margin-right:8.17%;margin-top:30pt;page-break-after:always;width:83.66%;border-width:0;"><div style="max-width:100%;padding-left:8.17%;padding-right:8.17%;position:relative;"><div style="margin-top:8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><font style="color:#ff0000;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;">to the Expenses of any Proceeding pursuant to the terms of this Agreement, regardless of whether the Company maintains D&amp;O Insurance covering Indemnitee. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(c)<font style="display:inline-block;width:24.9pt;"></font>Indemnitee shall be covered by the D&amp;O Insurance policies that the Company is required to maintain hereunder in such a manner as to provide Indemnitee the same rights and benefits as are provided to the most favorably insured of the Company&#8217;s directors, if Indemnitee is a director; or of the Company&#8217;s officers, if Indemnitee is not a director of the Company but is an officer; or of the Company&#8217;s key employees, agents or fiduciaries, if Indemnitee is not an officer or director but is a key employee, agent or fiduciary.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">7.</font></font><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Severability</b>. &#160;Nothing in this Agreement is intended to require or shall be construed as requiring the Company to do or fail to do any act in violation of applicable law. &#160;The Company&#8217;s inability, pursuant to court order, to perform its obligations under this Agreement shall not constitute a breach of this Agreement. &#160;The provisions of this Agreement shall be severable as provided in this Section 7. &#160;If this Agreement or any portion hereof shall be invalidated on any ground by any court of competent jurisdiction, then the Company shall nevertheless indemnify Indemnitee to the full extent permitted by any applicable portion of this Agreement that shall not have been invalidated, and the balance of this Agreement not so invalidated shall be enforceable in accordance with its terms.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">8.</font></font><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exceptions</b>. &#160;Any other provision herein to the contrary notwithstanding, the Company shall not be obligated pursuant to the terms of this Agreement:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(a) <font style="display:inline-block;width:22.4pt;"></font><b style="font-weight:bold;">Claims Initiated by Indemnitee</b>. &#160;To indemnify or advance expenses to Indemnitee with respect to Proceedings or claims initiated or brought voluntarily by Indemnitee and not by way of defense, other than: (i) Proceedings under Sections 4(b) or 4(c); (ii) Proceedings brought to establish or enforce a right to indemnification under this Agreement or the provisions of the Company&#8217;s Articles of Incorporation or Bylaws unless a court of competent jurisdiction determines that each of the material assertions made by Indemnitee in such Proceeding were not made in good faith or were frivolous; or (iii) proceedings or claims instituted by Indemnitee with the approval by the Board;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(b)<font style="display:inline-block;width:24.34pt;"></font><b style="font-weight:bold;">Unauthorized Settlement</b>. &#160;To indemnify Indemnitee under this Agreement for any amounts paid in settlement of a Proceeding covered hereby without the prior written consent of the Company to such settlement, which consent will not be unreasonably withheld provided that the Company&#8217;s consent is not required if the Company is refusing to indemnify or advance Expenses to Indemnitee;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(c)<font style="display:inline-block;width:24.9pt;"></font><b style="font-weight:bold;">Insured Claims</b>. &#160;To indemnify Indemnitee for expenses or liabilities of any type whatsoever (including, but not limited to, judgments, fines, ERISA excise taxes or penalties, and amounts paid in settlement) to the extent such expenses or liabilities have been paid directly to Indemnitee by an insurance carrier under a policy of officers&#8217; and directors; liability insurance maintained by the Company; or</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(d)<font style="display:inline-block;width:24.34pt;"></font><b style="font-weight:bold;">Claims Under Section 16(b)</b>. &#160;To indemnify Indemnitee for expenses or the payment of profits arising from the purchase and sale by Indemnitee of securities in violation of Section 16(b) of the Securities Exchange Act of 1934, as amended, or any similar successor statute.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">9.</font></font><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Witness Expenses</b>. &#160;The Company agrees to compensate Indemnitee for the reasonable value of Indemnitee&#8217;s time spent, and to reimburse Indemnitee for all Expenses (including reasonable attorneys&#8217; fees and travel costs) reasonably incurred by Indemnitee, in connection with being a witness, or if Indemnitee is threatened to be made a witness, with respect to any Proceeding, by reason of Indemnitee serving or having served as an Agent of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10.</font></font><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Attorneys&#8217; Fees</b>. &#160;In the event that any action is instituted by Indemnitee under this Agreement to enforce or interpret any of the terms hereof, Indemnitee shall be entitled to be paid all court costs and expenses, including reasonable attorneys&#8217; fees, incurred by Indemnitee with respect to such action, unless as a part of such action, the court of competent jurisdiction determines that each of the material assertions made by Indemnitee as a basis for such action were not made in good faith or were frivolous. &#160;In the event of an action instituted by or in the name of the Company under this Agreement or to enforce or interpret any of the terms of this Agreement, Indemnitee shall be entitled to be paid all court costs and expenses, including attorneys&#8217; fees, incurred </p></div><div style="clear:both;display:table;margin-bottom:23pt;min-height:20pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;">8</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.17%;margin-right:8.17%;margin-top:30pt;page-break-after:always;width:83.66%;border-width:0;"><div style="max-width:100%;padding-left:8.17%;padding-right:8.17%;position:relative;"><div style="margin-top:8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><font style="color:#ff0000;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;">by Indemnitee in defense of such action (including with respect to Indemnitee&#8217;s counterclaims and cross-claims made in such action), unless as a part of such action the court determines that each of Indemnitee&#8217;s material defenses to such action were made in bad faith or were frivolous.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">11.</font></font><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Duration</b>. &#160;All agreements and obligations of the Company contained herein shall continue during the period that Indemnitee is an Agent of the Company and shall continue thereafter (a) so long as Indemnitee may be subject to any possible claim for which Indemnitee may be indemnified hereunder (including any rights of appeal thereto) and (b) throughout the pendency of any Proceeding (including any rights of appeal thereto) commenced by Indemnitee to enforce or interpret Indemnitee&#8217;s rights under this Agreement, even if, in either case, Indemnitee may have ceased to serve in such capacity at the time of any such Proceeding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">12.</font></font><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Miscellaneous.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(a)<font style="display:inline-block;width:24.9pt;"></font><b style="font-weight:bold;">Governing Law</b>. &#160;This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of Utah, without giving effect to principles of conflict of law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(b)<font style="display:inline-block;width:24.34pt;"></font><b style="font-weight:bold;">Consent to Jurisdiction</b>. &#160;The Company and Indemnitee each hereby irrevocably consent to the jurisdiction of the courts of the State of Utah for all purposes in connection with any action or proceeding which arises out of or relates to this Agreement <b style="font-weight:bold;">and agree that any action instituted under this Agreement shall be commenced, prosecuted and continued only in the federal and state courts located in the State of Utah in and for Salt Lake County, which shall be the exclusive and only proper forum for adjudicating such a claim</b>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;text-indent:36pt;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(c)</font></font><b style="font-weight:bold;">Entire Agreement; Enforcement of Rights</b>. &#160;This Agreement sets forth the entire agreement and understanding of the parties relating to the subject matter herein and merges all prior discussions between them. &#160;No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing signed by the parties to this Agreement. &#160;The failure by either party to enforce any rights under this Agreement shall not be construed as a waiver of any rights of such party.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(d)<font style="display:inline-block;width:24.34pt;"></font><b style="font-weight:bold;">Construction</b>. &#160;This Agreement is the result of negotiations between and has been reviewed by each of the parties hereto and their respective counsel, if any; accordingly, this Agreement shall be deemed to be the product of all of the parties hereto, and no ambiguity shall be construed in favor of or against any one of the parties hereto.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(e)<font style="display:inline-block;width:24.9pt;"></font><b style="font-weight:bold;">Counterparts</b>. &#160;This Agreement may be signed in counterparts. &#160;This Agreement constitutes a separate agreement between the Company and Indemnitee and may be supplemented or amended as to Indemnitee only by a written instrument signed by the Company and Indemnitee, with such amendment binding only the Company and Indemnitee. &#160;All waivers must be in a written document signed by the party to be charged. &#160;No waiver of any of the provisions of this Agreement shall be implied by the conduct of the parties. &#160;A waiver of any right hereunder shall not constitute a waiver of any other right hereunder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(f)<font style="display:inline-block;width:26.01pt;"></font><b style="font-weight:bold;">Interpretation of Agreement</b>. &#160;This Agreement shall be interpreted and enforced so as to provide indemnification to Indemnitee to the fullest extent now or hereafter permitted by the Act.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(g)<font style="display:inline-block;width:24.34pt;"></font><b style="font-weight:bold;">Subrogation</b>. &#160;In the event of payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, who shall execute all documents required and shall do all acts that may be necessary to secure such rights and to enable the Company to effectively bring suit to enforce such rights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(h) &#160; <font style="display:inline-block;width:16.84pt;"></font><b style="font-weight:bold;">Continuation of Indemnity; Binding Effect</b>.<b style="font-weight:bold;"> &#160;</b>Indemnitee&#8217;s rights hereunder shall continue after Indemnitee has ceased acting an Agent of the Company and the benefits hereof shall inure to the benefit of the heirs, executors and administrators of Indemnitee. &#160;The Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially all or a substantial part, of the business and/or assets of the Company, by </p></div><div style="clear:both;display:table;margin-bottom:23pt;min-height:20pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;">9</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.17%;margin-right:8.17%;margin-top:30pt;page-break-after:always;width:83.66%;border-width:0;"><div style="max-width:100%;padding-left:8.17%;padding-right:8.17%;position:relative;"><div style="margin-top:8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><font style="color:#ff0000;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;">written agreement in form and substance satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;text-indent:36pt;margin:12pt 0pt 0pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(i)</font></font><b style="font-weight:bold;">Notices</b>. &#160;All notices, demands, consents, requests, approvals and other communications required or permitted hereunder shall be in writing and shall be deemed to have been properly given if hand delivered (effective upon receipt or when refused), or if sent by a courier freight prepaid (effective upon receipt or when refused), in the case of the Company, at the addresses listed below, or to such other addresses as the parties may notify each other in writing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>To Company:<font style="display:inline-block;width:17.42pt;"></font>Merit Medical Systems, Inc.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font>Attention: Chief Legal Officer</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font>1600 West Merit Parkway</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font>South Jordan, Utah 84095</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0"><tr><td style="width:72pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:72pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:0pt;text-align:justify;">To Indemnitee:</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin-bottom:0pt;margin-top:0pt;text-align:justify;">At Indemnitee&#8217;s residence address and facsimile number on the records of the Company from time to time.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">(j)</font></font><b style="font-weight:bold;">Evidence of Coverage</b>. &#160;Upon request by Indemnitee, the Company shall provide evidence of the liability insurance coverage required by this Agreement. &#160;The Company shall promptly notify Indemnitee of any change in the Company&#8217;s D&amp;O Insurance coverage.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">[</b><font style="font-style:italic;font-weight:bold;">Remainder of Page Intentionally Left Blank; Signatures appear on the following page</font><b style="font-weight:bold;">.]</b></p></div><div style="clear:both;display:table;margin-bottom:23pt;min-height:20pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;">10</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:8.17%;margin-right:8.17%;margin-top:30pt;page-break-after:always;width:83.66%;border-width:0;"><div style="max-width:100%;padding-left:8.17%;padding-right:8.17%;position:relative;"><div style="margin-top:8pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><font style="color:#ff0000;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt 0pt 12pt 0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>The parties hereto have agreed and accept this Agreement as of the day and year set forth on the first page of this Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font>MERIT MEDICAL SYSTEMS, INC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font>By: &#160;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"> &#160; &#160; /s/ Fred P. Lampropoulos</u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:11.5pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font>Name: Fred P. Lampropoulos</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font>Title: Chief Executive Officer</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;">INDEMNITEE:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;white-space:pre-wrap;">   </u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">/s/ Silvia M. Perez</u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:26.62pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:justify;margin:0pt;">Silvia M. Perez, an individual</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;">[<i style="font-style:italic;">Signature Page to Indemnification Agreement</i>]</p></div><div style="clear:both;display:table;margin-bottom:23pt;min-height:20pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;text-align:center;margin:0pt;">11</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:8.17%;margin-right:8.17%;margin-top:30pt;page-break-after:avoid;width:83.66%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>3
<FILENAME>mmsi-20240515xex3d1.htm
<DESCRIPTION>EX-3.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.125.0--><!--Created on: 5/21/2024 08:50:27 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">EXHIBIT 3.1 </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">FOURTH AMENDED AND RESTATED </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">BYLAWS </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">OF</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;padding-bottom:1pt;text-align:center;border-bottom:1.5pt solid #000000;margin:0pt;"><b style="font-weight:bold;">MERIT MEDICAL SYSTEMS, INC.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">May 16, 2024</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;">ARTICLE I.  OFFICES</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>The principal office of the Corporation in the State of Utah shall be located in the City of South Jordan, County of Salt Lake. &#160;The Corporation may have such other offices, either within or without the State of Utah, as the Board of Directors may designate or as the business of the Corporation may require from time to time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;">ARTICLE II.  SHAREHOLDERS</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 1.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Annual Meeting</u>. &#160;The annual meeting of the shareholders shall be held on a date and at a time designated by the Board of Directors, for the purpose of electing directors and for the transaction of such other business as may come before the meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 2.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Special Meetings</u>. &#160;Special meetings of the shareholders, for any purpose or purposes, unless otherwise prescribed by statute, may be called by the chief executive officer or by the Board of Directors, and shall be called by the chief executive officer at the request of the holders of not less than one-tenth (1/10) of all outstanding shares of the Corporation entitled to vote at the meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 3.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Place of Meeting</u>. &#160;The Board of Directors may designate any place, either within or without the State of Utah, as the place of meeting for any annual meeting or for any special meeting called by the Board of Directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 4.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notice of Meeting</u>. &#160;Written notice stating the place, day and hour of the meeting and, in case of a special meeting, the purpose or purposes for which the meeting is called, shall, unless otherwise prescribed by statute, be delivered not less than ten (10) nor more than sixty (60) days before the date of the meeting, either personally or by mail, by or at the direction of the chief executive officer, or the secretary, or the officer or other persons calling the meeting, to each shareholder of record entitled to vote at such meeting. &#160;If mailed, such notice shall be deemed to be delivered when deposited in the United States mail, addressed to the shareholder at his or her address as it appears on the stock transfer books of the Corporation, with postage thereon prepaid. &#160; </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 5.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Closing of Transfer Books and Fixing of Record Date</u>. &#160;For the purpose of determining shareholders entitled to notice of or to vote at any meeting of shareholders or any adjournment thereof, or shareholders entitled to receive payment of any dividend, or in order to make a determination of shareholders for any other proper purpose, the Board of Directors of the Corporation may provide that the stock transfer books shall be closed for a stated period, not less than ten (10) days, but not to exceed, in any case, sixty (60) days. In lieu of closing the stock transfer books, the Board of Directors may fix in advance a date as the record date for any such determination of shareholders, such date in any case to be not more than sixty (60) days and, in </p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;">case of a meeting of shareholders, not less than ten (10) days prior to the date of which the particular action, requiring such determination of shareholders is to be taken. If the stock transfer books are not closed and no record date is fixed for the determination of shareholders entitled to notice of or to vote at a meeting of shareholders, or shareholders entitled to receive payment of a dividend, the date on which notice of the meeting is mailed or the date on which the resolution of the Board of Directors declaring such dividend is adopted, as the case may be, shall be the record date for such determination of shareholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 6.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Voting Record</u>. &#160;The officer or agent having charge of the stock transfer books for shares of the Corporation shall make a complete record of the shareholders entitled to vote at each meeting of shareholders or any adjournment thereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 7.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Quorum</u>. &#160;A majority of the outstanding shares of the Corporation entitled to vote, represented in person or by proxy, shall constitute a quorum at a meeting of shareholders. &#160;If less than a majority of the outstanding shares are represented at a meeting, a majority of the shares so represented may adjourn the meeting from time to time without further notice.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 8.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Proxies</u>. &#160;At all meetings of shareholders, a shareholder may vote in person or by proxy executed in writing by the shareholder or by his or her duly authorized attorney in fact.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 9.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Voting of Shares</u>. &#160;Each outstanding share entitled to vote shall be entitled to one (1) vote upon each matter submitted to a vote at a meeting of shareholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 10.<font style="display:inline-block;width:18pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Informal Action by Shareholders</u>. &#160;Any action required to be taken at a meeting of the shareholders, or any action which may be taken at a meeting of the shareholders, may be taken without a meeting if a consent in writing, setting forth the action so taken, shall be signed by all of the shareholders entitled to vote with respect to the subject matter thereof.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:72pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Section 11. </font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Transaction of Business at Meeting</u>. &#160;No business may be transacted at an annual meeting of shareholders, other than business that is either (a) specified in the notice of meeting (or any supplement thereto) given by or at the direction of the Board of Directors (or any duly authorized committee thereof), (b) otherwise properly brought before the annual meeting by or at the direction of the Board of Directors (or any duly authorized committee thereof) or (c) otherwise properly brought before the annual meeting by any shareholder of the Corporation (i) who is a shareholder of record on the date of the giving of the notice provided for in this Section 11 and on the record date for the determination of shareholders entitled to vote at such annual meeting and (ii) who complies with the notice procedures set forth in this Section 11. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>In addition to any other applicable requirements, for business to be properly brought before an annual meeting by a shareholder, such shareholder must have given timely notice thereof in proper written form to the Secretary of the Corporation. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>To be timely, a shareholder&#39;s notice to the Secretary must be delivered to or mailed and received at the principal executive offices of the Corporation not later than the close of business on the 120<sup style="font-size:9pt;vertical-align:top;">th</sup> day in advance of the anniversary of the previous year&#8217;s annual meeting of shareholders, nor earlier than the close of business on the 150<sup style="font-size:9pt;vertical-align:top;">th</sup> day in advance of the anniversary date of the previous year&#8217;s annual meeting of shareholders; provided, however, that if the Corporation did not hold an annual meeting of shareholders the previous year, or if the annual meeting is called for a date that is not within thirty (30) days before or after such anniversary date, </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><div style="clear:right;float:right;margin-right:calc(50% - 0pt);"><div style="left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;width:100%;margin:0pt;"> 2</p></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;">notice by the shareholder in order to be timely must be so received not later than the close of business on the tenth (10th) day following the day on which such notice of the date of the annual meeting was mailed or such public disclosure of the date of the annual meeting was made, whichever first occurs. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>To be in proper written form, a shareholder&#39;s notice to the Secretary must set forth as to each matter such shareholder proposes to bring before the annual meeting (i) a brief description of the business desired to be brought before the annual meeting and the reasons for conducting such business at the annual meeting, (ii) the name and record address of such shareholder, (iii) the class and series and number of shares of each class and series of stock of the Corporation which are owned beneficially or of record by such shareholder, (iv) a description of all arrangements or understandings between such shareholder and any other person or persons (including their names) in connection with the proposal of such business by such shareholder and any material interest of such shareholder in such business and (v) a representation that such shareholder is a holder of record of stock of the Corporation entitled to vote at such meeting and that such shareholder intends to appear in person or by proxy at the annual meeting to bring such business before the meeting. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>In addition, notwithstanding anything in this Section 11 to the contrary, a shareholder intending to nominate one or more persons for election as a director at an annual or special meeting of shareholders must comply with Section 11 of Article III for such nominations to be properly brought before such meeting. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>No business shall be conducted at the annual meeting of shareholders except business brought before the annual meeting in accordance with the procedures set forth in this Section 11; provided, however, that, once business has been properly brought before the annual meeting in accordance with such procedures, nothing in this Section 11 shall be deemed to preclude discussion by any shareholder of any such business. &#160;If the presiding officer of the annual meeting determines that business was not properly brought before the annual meeting in accordance with the foregoing procedures, the presiding officer of the annual meeting shall declare to the meeting that the business was not properly brought before the meeting and such business shall not be transacted. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>No business shall be conducted at a special meeting of shareholders except for such business as shall have been brought before the meeting pursuant to the Corporation&#39;s notice of meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;">ARTICLE III.  BOARD OF DIRECTORS</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 1.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">General Powers</u>. &#160;The business and affairs of the Corporation shall be managed by its Board of Directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:72pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Section 2.</font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Number, Tenure and Qualifications</u>. &#160;The Board of Directors shall consist of such number of members, which number shall not be less than three and not more than eleven as may be determined and established from time to time by the Board of Directors and shall be divided into three classes, as nearly equal in size as possible. &#160;No increase in the maximum number of members shall be made except upon the affirmative vote of not less than two-thirds of the outstanding capital stock of the Corporation entitled to vote thereon. &#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 3.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Regular Meetings</u>. &#160;A regular meeting of the Board of Directors shall be held without other notice than this Bylaw immediately after, and at the same place as, the annual </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><div style="clear:right;float:right;margin-right:calc(50% - 0pt);"><div style="left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;width:100%;margin:0pt;"> 3</p></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;">meeting of shareholders. &#160;The Board of Directors may provide, by resolution, the time and place, either within or without the State of Utah, for the holding of additional regular meetings without other notice than such resolution.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:72pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Section 4.</font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Special Meetings</u>. &#160;Special meetings of the Board of Directors may be called by or at the request of the chief executive officer or any two directors. &#160;The person or persons authorized to call special meetings of the Board of Directors may fix any place, either within or without the State of Utah, as the place for holding any special meeting of the Board of Directors called by them.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 5.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Notice</u>.<font style="display:inline-block;width:1.01pt;"></font> &#160; &#160;Notice of any special meeting of the Board of Directors shall be given by oral, telegraphic, written, electronic-mail or other electronic notice duly given, sent or mailed to each director not less than twenty-four (24) hours before such meeting. &#160;Any director may waive notice of any meeting. &#160;The attendance of a director at a meeting shall constitute a waiver of notice of such meeting, except where a director attends a meeting for the express purpose of objecting to the transaction of any business because the meeting is not lawfully called or convened.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 6.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Quorum</u>. &#160;A majority of the number of directors fixed by Section 2 of this Article III shall constitute a quorum for the transaction of business at any meeting of the Board of Directors, but if less than such majority is present at a meeting, a majority of the directors present may adjourn the meeting from time to time without further notice.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 7.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Manner of Acting</u>. &#160;The act of a majority present at a meeting shall be the act of the Board of Directors, provided a quorum is present.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 8.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Action Without a Meeting</u>. &#160;Any action required or permitted to be taken by the Board of Directors at a meeting may be taken without a meeting if a consent in writing, setting forth the action so taken, shall be signed by all of the directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 9.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Vacancies</u>. &#160;Any vacancy occurring in the Board of Directors may be filled by the affirmative vote of a majority of the remaining directors though less than a quorum of the Board of Directors. &#160;A director elected to fill a vacancy shall be elected for the unexpired term of his or her predecessor in office. &#160;Any directorship to be filled by reason of an increase in the number of directors may be filled by election by the Board of Directors for a term of office continuing only until the next election of directors by the shareholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 10.<font style="display:inline-block;width:18pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Compensation</u>. &#160;By resolution of the Board of Directors, the Directors may be paid their expenses, if any, of attendance at each meeting of the Board of Directors, and may be paid a fixed sum for attendance at each meeting of the Board of Directors or a stated salary as Director. &#160;No such payment shall preclude any Director from serving the Corporation in any other capacity and receiving compensation therefore.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:72pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Section 11.</font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Nominations of Directors by Shareholders</u>. &#160;Only persons who are nominated in accordance with the following procedures shall be eligible for election as directors of the Corporation, subject to the rights of holders of any class or series of stock having a preference over the Common Stock as to dividends or upon liquidation to elect directors under specified circumstances. &#160;Nominations of persons for election to the Board of Directors may be made at any annual meeting of shareholders, or at any special meeting of shareholders called for </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><div style="clear:right;float:right;margin-right:calc(50% - 0pt);"><div style="left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;width:100%;margin:0pt;"> 4</p></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;">the purpose of electing directors, (a) by or at the direction of the Board of Directors (or any duly authorized committee thereof) or (b) by any shareholder of the Corporation (i) who is a shareholder of record on the date of the giving of the notice provided for in this Section 11 and on the record date for the determination of shareholders entitled to vote at such meeting and (ii) who complies with the notice procedures set forth in this Section 11. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>In addition to any other applicable requirements, for a nomination to be made by a shareholder, such shareholder must have given timely notice thereof in proper written form to the Secretary of the Corporation. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>To be timely, a shareholder&#39;s notice to the Secretary must be delivered to or mailed and received at the principal executive offices of the Corporation (a) in the case of an annual meeting, not later than the close of business on the 120<sup style="font-size:9pt;vertical-align:top;">th</sup> day in advance of the anniversary of the previous year&#8217;s annual meeting of shareholders, nor earlier than the close of business on the 150<sup style="font-size:9pt;vertical-align:top;">th</sup> day in advance of the anniversary date of the previous year&#8217;s annual meeting of shareholders; provided, however, that if the Corporation did not hold an annual meeting of shareholders the previous year, or if the annual meeting is called for a date that is not within thirty (30) days before or after such anniversary date, notice by the shareholder in order to be timely must be so received not later than the close of business on the tenth (10th) day following the day on which such notice of the date of the annual meeting was mailed or such public disclosure of the date of the annual meeting was made, whichever first occurs; and (b) in the case of a special meeting of shareholders called for the purpose of electing directors, not later than the close of business on the tenth (10th) day following the day on which notice of the date of the special meeting was mailed or public disclosure of the date of the special meeting was made, whichever first occurs. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>To be in proper written form, a shareholder&#39;s notice to the Secretary must set forth (a) as to each person whom the shareholder proposes to nominate for election as a director (i) the name, age, business address and residence address of the person, (ii) the principal occupation and employment of the person, (iii) the class and series and number of shares of each class and series of capital stock of the Corporation which are owned beneficially or of record by the person and (iv) any other information relating to the person that would be required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for election of directors pursuant to Section 14 of the Securities Exchange Act of 1934, as amended (the &quot;Exchange Act&quot;) (or in any law or statute replacing such section), and the rules and regulations promulgated thereunder; and (b) as to the shareholder giving the notice (i) the name and record address of such shareholder, (ii) the class and series and number of shares of each class and series of capital stock of the Corporation which are owned beneficially or of record by such shareholder, (iii) a description of all arrangements or understandings between such shareholder and each proposed nominee and any other person or persons (including their names) pursuant to which the nomination(s) are to be made by such shareholder, (iv) a representation that such shareholder is a holder of record of stock of the Corporation entitled to vote at such meeting and that such shareholder intends to appear in person or by proxy at the meeting to nominate the person or persons named in its notice and (v) any other information relating to such shareholder that would be required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for election of directors pursuant to Section 14 of the Exchange Act (or in any law or statute replacing such section) and the rules and regulations promulgated thereunder. Such notice must be accompanied by a written consent of each proposed nominee to being named as a nominee and to serve as a director if elected. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><div style="clear:right;float:right;margin-right:calc(50% - 0pt);"><div style="left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;width:100%;margin:0pt;"> 5</p></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>No person shall be eligible for election as a director of the Corporation unless nominated in accordance with the procedures set forth in this Section 11. &#160;If the presiding officer of the annual meeting determines that a nomination was not made in accordance with the foregoing procedures, the presiding officer of the annual meeting shall declare to the meeting that the nomination was defective and such defective nomination shall be disregarded.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:72pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Section 12.</font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Majority Voting</u>. &#160;A nominee for director shall be elected to the Board of Directors if a majority of the votes cast are in favor of such nominee&#8217;s election; provided, however, that, if the number of nominees for director exceeds the number of directors to be elected, directors shall be elected by a plurality of the votes of the shares represented in person or by proxy at any meeting of shareholders held to elect directors and entitled to vote on such election of directors. &#160;For purposes of this Section 12, a majority of votes cast means that the number of shares voted &#8220;for&#8221; the election of a director must exceed the number of votes cast &#8220;against&#8221; the election of that director. &#160;If an incumbent director is not re-elected, the director shall tender his or her resignation to the Board of Directors. &#160;The Nominating and Corporate Governance Committee of the Board of Directors will make a recommendation to the Board of Directors on whether to accept or reject the resignation, or whether other action should be taken. &#160;The Board of Directors will act on the recommendation of the Nominating and Corporate Governance Committee and publicly disclose its decision within 90 days from the date of the certification of the election results. &#160;An incumbent director who tenders his or her resignation to the Board of Directors pursuant to this Section 12 will not participate in the decision of the Board of Directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:72pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Section 13</font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Committees of Directors</u>. &#160;The Board of Directors may, by resolution passed by a majority of directors fixed by Section 2 of this Article III, designate one or more committees, each committee to consist of two or more of the directors of the Corporation. &#160;The Board of Directors may designate one or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee. &#160;Any such committee may exercise, to the extent specified by the Articles of Incorporation or these Bylaws and authorized by the Board of Directors, the authority of the Board of Directors under Section 16-10a-801 of the Utah Revised Business Corporation Act (the &#8220;Act&#8221;), except as otherwise provided by law. &#160;Such committee or committees shall have such name or names as may be determined from time to time by resolution adopted by the Board of Directors. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;">ARTICLE IV.  OFFICERS</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 1.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Number</u>. &#160;The officers of the Corporation shall be a Chief Executive Officer, a President, a Vice-President, a Secretary, and a Treasurer, each of whom shall be elected by a majority of the Board of Directors. &#160;Such other officers and assistant officers as may be deemed necessary may be elected or appointed by the Board of Directors. &#160;In its discretion, the Board of Directors may leave unfilled for any such period as it may determine any office except those of Chief Executive Officer and Secretary.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:72pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Section 2.</font></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Election and Term of Office</u>. &#160;The officers of the Corporation to be elected by the Board of Directors shall be elected annually by the Board of Directors at the first meeting of the Board of Directors held after each annual meeting of the shareholders. &#160;If the election of officers shall not be held at such meeting, such election shall be held as soon thereafter as convenient. &#160;Each officer shall hold office until his or her successor shall have been duly elected </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><div style="clear:right;float:right;margin-right:calc(50% - 0pt);"><div style="left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;width:100%;margin:0pt;"> 6</p></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;">and shall have qualified or until his or her death or until he or she shall resign or shall have been removed in the manner hereinafter provided.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 3.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Removal</u>. &#160;Any officer may be removed by the Board of Directors whenever in its judgment the best interests of the Corporation will be served thereby, but such removal shall be without prejudice to the contract rights, if any, of the person so removed. &#160;Election or appointment of an officer or agent shall not of itself create contract rights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 4.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Vacancies</u>. &#160;A vacancy in any office because of death, resignation, removal, disqualification or otherwise, may be filled by the Board of Directors for the unexpired portion of the term.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 5.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Chief Executive Officer</u>. &#160;The Chief Executive Officer shall be the principal executive officer of the Corporation and subject to the control of the Board of Directors, shall in general supervise and control all of the business and affairs of the Corporation. &#160;He or she shall, when present, preside at all meetings of the shareholders and of the Board of Directors. &#160;He or she may sign, with the president, the secretary or any other proper officer of the Corporation thereunto authorized by the Board of Directors, certificates for shares of the Corporation, any deeds, mortgages, bonds, contracts, or other instruments which the Board of Directors has authorized to be executed, except in cases where the signing and execution thereof shall be expressly delegated by the Board of Directors or by these Bylaws to some other officer or agent of the Corporation, or shall be required by law to be otherwise signed or executed; and in general shall perform all duties incident to the office of chief executive officer and such other duties as may be prescribed by the Board of Directors from time to time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt 36pt 0pt 36pt;"><font style="margin-left:0pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Courier New';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:72pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-style:normal;font-weight:normal;">Section 6.</font></font><u style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">President</u><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">. &#160;The President shall, subject to the direction and supervision of the chief executive officer: (i) be responsible for the operational affairs of the corporation; and (ii) assist the chief executive officer and perform such duties as may be assigned by the chief executive officer or by the Board of Directors.&#160; Such officer shall, at the request of the chief executive officer, or in the absence of the chief executive officer, or in the event of his or her inability or refusal to act, perform the duties of the chief executive officer and when so acting, shall have all the powers of and be subject to all the restrictions on the chief executive officer.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 7.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Vice-President</u>. &#160;In the absence of the president or in the event of his or her death, inability or refusal to act, the vice-president shall perform the duties of the president, and when so acting, shall have all the powers of and be subject to all the restrictions upon the president. &#160;A vice-president may sign, with the secretary, certificates for shares of the Corporation; and shall perform such other duties as from time to time may be assigned to him or her by the chief executive officer or by the Board of Directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 8.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Secretary</u>. &#160;The secretary shall: &#160;(a) keep the minutes of the proceedings of the shareholders and of the Board of Directors in one or more books provided for that purpose; (b) see that all notices are duly given in accordance with the provisions of these Bylaws or as required by law; (c) be custodian of the corporate records and of the seal of the Corporation and see that the seal of the Corporation, if such a seal has been adopted by the Board of Directors, is affixed to all documents the execution of which on behalf of the Corporation under its seal is duly authorized; (d) keep a register of the post office address of each shareholder; (e) sign with the chief executive officer, the president, or the vice-president, certificates for shares of the Corporation, the issuance of which shall have been authorized by resolution of the Board of Directors; (f) have general charge </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><div style="clear:right;float:right;margin-right:calc(50% - 0pt);"><div style="left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;width:100%;margin:0pt;"> 7</p></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;">of the stock transfer books of the Corporation; and (g) in general perform all duties incident to the office of secretary and such other duties as from time to time may be assigned to him or her by the chief executive officer or by the Board of Directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 9.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Treasurer</u>. &#160;The treasurer shall: &#160;(a) have charge and custody of and be responsible for all funds and securities of the Corporation; (b) receive and give receipts for moneys due and payable to the Corporation from any source whatsoever, and deposit all such moneys in the name of the Corporation in such banks, trust companies or other depositories as shall be selected in accordance with the provisions of Article V of these Bylaws; and (c) in general perform all of the duties incident to the office of treasurer and such other duties as from time to time may be assigned to him or her by the chief executive officer or by the Board of Directors. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 10.<font style="display:inline-block;width:18pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Salaries</u>. &#160;The salaries of the officers shall be fixed from time to time by the Board of Directors and no officer shall be prevented from receiving such salary by reason of the fact that he or she is also a director of the Corporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;">ARTICLE V.  CERTIFICATES FOR SHARE AND THEIR TRANSFER</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 1.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Certificates for Shares</u>. &#160;Certificates representing shares of the Corporation shall be in such form as shall be determined by the Board of Directors. &#160;Such certificate shall be signed by the chief executive officer, president or any other proper officer of the corporation thereunto authorized by the Board of Directors and by the secretary and sealed with the corporate seal or a facsimile thereof if such seal has been adopted by the Board of Directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 2.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Transfer of Shares</u>. &#160;Transfer of shares of the Corporation shall be made only on the stock transfer books of the Corporation by the holder of record thereof or by his or her legal representative, who shall furnish proper evidence of authority to transfer, or by his or her attorney thereunto authorized by power of attorney duly executed and filed with the secretary of the Corporation, and on surrender for cancellation of the certificate for such shares. &#160;The person in whose name shares stand on the books of the Corporation shall be deemed by the Corporation to be the owner thereof for all purposes. &#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;">ARTICLE VI.  FISCAL YEAR</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>The fiscal year of the Corporation shall begin on the first day of January and end on the thirty-first day of December in each year.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;">ARTICLE VII.  DIVIDENDS</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>The Board of Directors may, from time to time, declare and the Corporation may pay dividends on its outstanding shares in the manner, and upon the terms and conditions provided by law and its Articles of Incorporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;">ARTICLE VIII.  CORPORATE SEAL</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>The Board of Directors may provide a corporate seal which shall be circular in form and shall have inscribed thereon the name of the Corporation and the state of incorporation and the words, &#8220;Corporate Seal.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><div style="clear:right;float:right;margin-right:calc(50% - 0pt);"><div style="left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;width:100%;margin:0pt;"> 8</p></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;">ARTICLE IX.  WAIVER OF NOTICE</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Whenever any notice is required to be given to any shareholder or director of the Corporation under the provisions of these Bylaws or under the provisions of the Act, a waiver thereof in writing signed by the person or persons entitled to such notice, whether before or after the time stated therein, shall be deemed equivalent to the giving of such notice.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;">ARTICLE X.  AMENDMENTS</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>These Bylaws may be altered, amended or repealed and new Bylaws may be adopted by the Board of Directors or by the shareholders at any regular or special meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;"><font style="white-space:pre-wrap;">ARTICLE XI.  INDEMNIFICATION</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 1.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Voluntary Indemnification</u>. (a) Unless otherwise provided in the Articles of Incorporation, the Corporation shall indemnify any individual made a party to a proceeding because he is or was a director or officer of the Corporation, against liability incurred in the proceeding, but only if the Corporation has authorized the payment in accordance with the applicable statutory provisions, including Sections 16-10a-902,16-10a-904, 16-10a-906, and 16-10a-907 of the Act, and a determination has been made in accordance with the procedures set forth in such provisions that the director or officer conducted himself in good faith; that he reasonably believed that his conduct, if in his official capacity with the Corporation, was in its best interests and that his conduct, in all other cases, was at least not opposed to the Corporation&#39;s best interests; and that he had no reasonable cause to believe his conduct was unlawful in the case of any criminal proceeding. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(b) &#160;The Corporation may not voluntarily indemnify a director or officer in connection with a proceeding by or in the right of the Corporation in which the director or officer was adjudged liable to the Corporation or in connection with any other proceeding charging improper personal benefit to him, whether or not involving action in his official capacity, in which he was adjudged liable on the basis that personal benefit was improperly received by him. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(c) &#160;Indemnification permitted under this Section 1 in connection with a proceeding by or in the right of the Corporation is limited to reasonable expenses incurred in connection with the proceeding. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>(d) &#160;If a determination is made, using the procedures set forth in the applicable statutory provisions, that the director or officer has satisfied the requirements listed herein and if an authorization of payment is made, using the procedures and standards set forth in the applicable statutory provision, then, unless otherwise provided in the Articles of Incorporation, the Corporation shall pay for or reimburse the reasonable expenses incurred by a director or officer who is a party to a proceeding in advance of the final disposition of the proceeding if the director or officer furnishes the Corporation a written affirmation of his good faith belief that he has satisfied the standard of conduct described in this Section 1 and applicable law, furnishes the Corporation a written undertaking, executed personally or on his behalf, to repay the advance if it is ultimately determined that he did not meet the standard of conduct (which undertaking must be an unlimited general obligation of the director or officer, but need not be secured and may be accepted without reference to financial ability to make repayment); and if a determination is made </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><div style="clear:right;float:right;margin-right:calc(50% - 0pt);"><div style="left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;width:100%;margin:0pt;"> 9</p></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;">that the facts then known of those making the determination would not preclude indemnification under this Section 1 and applicable law. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 2.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Mandatory Indemnification</u>. &#160;Unless otherwise provided in the Corporation&#39;s Articles of Incorporation, the Corporation shall indemnify a director or officer of the Corporation who was wholly successful, on the merits or otherwise, in the defense of any proceeding, or in the defense of any claim, issue, or matter in the proceeding, to which he was a party because he is or was a director or officer of the Corporation against reasonable expenses incurred by him in connection with the proceeding or claim with respect to which he has been successful. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 3. &#160;<font style="display:inline-block;width:18pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Court-Ordered Indemnification</u>. &#160;Unless otherwise provided in the Corporation&#39;s Articles of Incorporation, a director or officer of the Corporation who is or was a party to a proceeding may apply for indemnification to the court conducting the proceeding or to another court of competent jurisdiction. The court may order indemnification if it determines that the director or officer is entitled to mandatory indemnification as provided in this Section 3 and applicable law, in which case the court shall also order the Corporation to pay the reasonable expenses incurred by the director or officer to obtain court-ordered indemnification. The court may also order indemnification if it determines that the director or officer is fairly and reasonably entitled to indemnification in view of all the relevant circumstances, whether or not the director or officer met the applicable standard of conduct set forth in Section 1 of this Article XI and applicable law. Any indemnification with respect to any proceeding in which liability has been adjudged in the circumstances described in paragraph (b) of Section 1 of this Article XI is limited to reasonable expenses. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 4. &#160;<font style="display:inline-block;width:18pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Indemnification of Others; Advancement of Expenses</u>. &#160;Unless otherwise provided in the Corporation&#39;s Articles of Incorporation, an incorporator, employee, fiduciary, or agent of the Corporation performing acts in furtherance of the business of the corporation shall have the same indemnification as provided to a director or officer in accordance with the conditions set forth in Section 1 of this Article XI. &#160; With respect to the advancement of expenses and other relief, the Board of Directors may, but shall not be required to, advance expenses to any such incorporator, employee, fiduciary, or agent of the Corporation, to any extent consistent with public policy and as provided for by the Articles of Incorporation, these Bylaws, general or specific action of the Board of Directors, or contract. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 5. &#160;<font style="display:inline-block;width:18pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Insurance</u>. &#160;The Corporation may purchase and maintain liability insurance on behalf of a person who is or was an incorporator, director, officer, employee, fiduciary, or agent or the Corporation, or who, while serving as an incorporator, director, officer, employee, fiduciary, or agent of the Corporation, is or was serving at the request of the Corporation as an incorporator, director, officer, partner, trustee, employee, fiduciary or agent of another foreign or domestic corporation or other person, or of an employee benefit plan, against liability asserted against or incurred by him in that capacity or arising from his status as an incorporator, director, officer, employee, fiduciary, or agent, whether or not the Corporation has the power to indemnify him against the same liability under applicable law. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 6. <font style="display:inline-block;width:21.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Nonexclusivity of Indemnification and Advancement of Expenses</u>. &#160;The indemnification and, to the extent set forth herein, advancement of expenses, provided by or granted pursuant to this Article XI shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under the Articles of </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><div style="clear:right;float:right;margin-right:calc(50% - 0pt);"><div style="left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;width:100%;margin:0pt;"> 10</p></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;">Incorporation, the Bylaws, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such person&#39;s official capacity and as to action in another capacity while holding such office, it being the policy of the Corporation that indemnification of the persons specified in this Article XI shall be made to the fullest extent permitted by law. &#160;The provisions of this Article XI shall not be deemed to preclude the indemnification of any person who is not specified in this Article XI but whom the Corporation has the power or obligation to indemnify under the provisions of the Act, or otherwise. </p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 7.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Survival of Indemnification and Advancement of Expenses</u>. &#160;The indemnification and, to the extent applicable, advancement of expenses provided by or granted pursuant to this Article XI shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director, officer, employee, fiduciary or agent, and shall inure to the benefit of the heirs, executors and administrators of such a person.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></font>Section 8.<font style="display:inline-block;width:24.01pt;"></font><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Limitation on Indemnification</u>. &#160;Notwithstanding anything contained in this Article XI to the contrary, except for proceedings to enforce rights to indemnification, the Corporation shall not be obligated to indemnify any incorporator, director, officer, employee, fiduciary or agent (or his or her heirs, executors or personal or legal representatives) or advance expenses in connection with a proceeding (or part thereof) initiated by such person unless such proceeding (or part thereof) was authorized or consented to by the Board of Directors of the Corporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:center;margin:0pt;">[<i style="font-style:italic;">Signature page follows</i>]</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"></font><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="display:none;font-size:12pt;line-height:0pt;text-align:justify;text-indent:36pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><div style="clear:right;float:right;margin-right:calc(50% - 0pt);"><div style="left:0pt;position:relative;text-indent:0pt;top:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;width:100%;margin:0pt;"> 11</p></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;text-indent:36pt;margin:0pt;">IN WITNESS WHEREOF, these Fourth Amended and Restated Bylaws have been executed by the Corporation as of the date first written above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;text-align:justify;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 0pt 36pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><b style="font-weight:bold;text-transform:uppercase;">Merit Medical Systems, Inc.,</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 0pt 36pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font>a Utah corporation</p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 0pt 36pt;"><font style="margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 0pt 36pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font>By: <u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:15.66pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;"><u style="display:inline-block;overflow:hidden;position:relative;text-align:justify;text-align-last:justify;text-decoration:underline;text-indent:0pt;vertical-align:bottom;white-space:normal;width:36pt;">&#8203; &#8203;<font style="display:inline-block;height:0pt;width:100%;"></font></u></u></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 0pt 252pt;"><font style="display:inline-block;width:18pt;"></font><font style="white-space:pre-wrap;">Name:   Brian G. Lloyd</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt 0pt 0pt 270pt;"><font style="white-space:pre-wrap;">Title:     Chief Legal Officer and              Secretary</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">[<i style="font-style:italic;">Fourth A&amp;R Bylaws &#8211; Signature Page</i>]</p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>mmsi-20240515xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.6.125.0--><!--Created on: 5/21/2024 08:50:26 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 0pt 7.5pt 0pt;"><b style="font-family:'Calibri Light';font-weight:bold;">EXHIBIT 99.1</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt 0pt 7.5pt 0pt;"><font style="font-family:'Calibri Light';font-size:14pt;">Merit Medical Shareholders Elect Silvia M. Perez as New Director</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><i style="font-family:'Calibri Light';font-style:italic;letter-spacing:0.1pt;background:#ffffff;">Experienced healthcare veteran brings a broad background spanning clinical, regulatory, operations, marketing, and business leadership to Merit&#8217;s Board of Directors.</i></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="font-family:'Calibri Light';letter-spacing:0.1pt;background:#ffffff;">SOUTH JORDAN, Utah, May 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced </font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;background:#ffffff;">that its shareholders elected&#160;</font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;background:#ffffff;">Silvia M. Perez</font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;background:#ffffff;">, </font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;background:#ffffff;">President </font><a name="_cp_change_1"></a><font style="font-family:'Calibri Light';letter-spacing:0.1pt;background:#ffffff;">of the</font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;white-space:pre-wrap;background:#ffffff;"> Commercial Branding and Transportation Division at 3M Company, as a director in Merit&#8217;s Annual Meeting of Shareholders held on May 15, 2024.  Merit&#8217;s shareholders also re-elected Fred P. Lampropoulos and Stephen C. Evans as directors.  Ms. Perez and Messrs. Lampropoulos and Evans were elected to serve three-year terms.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Calibri Light';letter-spacing:0.1pt;background:#ffffff;">&quot;We are pleased to welcome&#160;Silvia Perez&#160;as our newest director,&#8221; said Mr. Lampropoulos, Merit&#8217;s Chairman and Chief Executive Officer. &#8220;Her expertise and proven track record of leadership success will provide valuable industry and organizational perspective to both the board and the company&#8217;s management team as&#160;we pursue our continued growth initiatives.&#8221; </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:14pt 0pt 0pt 0pt;"><font style="font-family:'Calibri Light';letter-spacing:0.1pt;background:#ffffff;">&#8220;I&#39;m honored to join the Merit Board of Directors,&#8221; Perez said. &#8220;I believe in the company&#39;s mission to improve and save lives around the globe. I&#39;m excited to bring my experience to the team as they propel this mission forward.&quot;&#160;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:14pt 0pt 8pt 0pt;"><font style="font-family:'Calibri Light';letter-spacing:0.1pt;background:#ffffff;">Ms. Perez has worked for more than two decades in the healthcare industry, with accomplishments in clinical, regulatory, operations, marketing, and business leadership.&#160;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="font-family:'Calibri Light';letter-spacing:0.1pt;background:#ffffff;">She joined 3M Company in 1994 and has held a variety of leadership roles across the organization, both domestic and international. Roles include President of Commercial Solutions Division and </font><a name="_cp_change_4"></a><font style="font-family:'Calibri Light';letter-spacing:0.1pt;background:#ffffff;">Vice</font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;background:#ffffff;"> President of Acelity, Inc., which was the largest acquisition in the history of 3M Company. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="font-family:'Calibri Light';letter-spacing:0.1pt;background:#ffffff;">Ms. Perez </font><a name="_cp_change_7"></a><font style="font-family:'Calibri Light';letter-spacing:0.1pt;background:#ffffff;">holds</font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;background:#ffffff;"> a pharmaceutical chemist </font><a name="_cp_change_9"></a><font style="font-family:'Calibri Light';letter-spacing:0.1pt;background:#ffffff;">degree from</font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;background:#ffffff;"> the University of the Republic (Uruguay), and is an industrial pharmacist educated at the Federal University of Parana (Brazil). She holds Six Sigma Black Belt and Master Black Belt certifications.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="font-family:'Calibri Light';letter-spacing:0.1pt;visibility:hidden;background:#ffffff;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;padding-bottom:8pt;margin:0pt;"><font style="font-family:'Calibri Light';letter-spacing:0.1pt;">ABOUT MERIT MEDICAL Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling more than 700 individuals. Merit employs approximately 7,000 people worldwide.&#160;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;padding-bottom:14pt;background:#ffffff;margin:0pt;"><font style="font-family:'Calibri Light';letter-spacing:0.1pt;">TRADEMARKS Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc.,&#8239;its subsidiaries, or its licensors.&#160;&#160;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;background:#ffffff;margin:0pt;"><font style="font-family:'Calibri Light';letter-spacing:0.1pt;">CONTACTS&#160;</font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;"><br></font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;">PR/Media Inquiries&#160;</font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;"><br></font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;">Sarah Comstock&#160;</font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;"><br></font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;">Merit Medical&#160;</font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;"><br></font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;">+1-801-432-2864&#160;</font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;text-decoration-line:none;">|&#8239;sarah.comstock@merit.com</font><font style="color:#293849;font-family:'Calibri Light';letter-spacing:0.1pt;">&#160;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:14pt 0pt 8pt 0pt;"><font style="font-family:'Calibri Light';letter-spacing:0.1pt;">INVESTOR INQUIRIES&#160;</font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;"><br></font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;">Mike Piccinino, CFA, IRC&#160;</font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;"><br></font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;">Westwicke - ICR&#160;</font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;"><br></font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;">+1-443-213-0509&#160;</font><font style="font-family:'Calibri Light';letter-spacing:0.1pt;text-decoration-line:none;">|&#8239;mike.piccinino@westwicke.com</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="font-family:'Calibri Light';font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="display:none;line-height:0pt;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';font-size:0pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;table-layout:auto;width:85.47%;" align="center"><tr><td colspan="2" style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;">Summary report: </b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;">Litera Compare for Word 11.8.0.56 Document comparison done on 5/16/2024 8:45:26 AM</b></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;">Style name: </b><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">Default Style</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;">Intelligent Table Comparison: </b><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">Active</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;">Original filename: </b><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">Silvia Perez Press Release_05_16_24 (DRAFT 05.13.24).docx</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;">Modified filename: </b><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">Silvia Perez Press Release_05_16_24 (DRAFT 05.14.24).docx</font></p></td></tr><tr><td colspan="2" style="vertical-align:top;width:100%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;">Changes: </b></p></td></tr><tr><td style="vertical-align:top;width:77.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><u style="border-bottom-style:solid;border-bottom-width:0.5pt;color:#0000ff;font-family:'Times New Roman','Times','serif';font-size:12pt;text-decoration-line:underline;text-decoration-style:double;">Add </u></p></td><td style="vertical-align:top;width:22.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">4</font></p></td></tr><tr><td style="vertical-align:top;width:77.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="color:#ff0000;font-family:'Times New Roman','Times','serif';font-size:12pt;text-decoration-line:line-through;text-decoration-style:solid;">Delete </font></p></td><td style="vertical-align:top;width:22.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">6</font></p></td></tr><tr><td style="vertical-align:top;width:77.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="color:#008000;font-family:'Times New Roman','Times','serif';font-size:12pt;text-decoration-line:line-through;text-decoration-style:solid;">Move From</font></p></td><td style="vertical-align:top;width:22.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">0</font></p></td></tr><tr><td style="vertical-align:top;width:77.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><u style="border-bottom-style:solid;border-bottom-width:0.5pt;color:#008000;font-family:'Times New Roman','Times','serif';font-size:12pt;text-decoration-line:underline;text-decoration-style:double;">Move To</u></p></td><td style="vertical-align:top;width:22.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">0</font></p></td></tr><tr><td style="vertical-align:top;width:77.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><u style="border-bottom-style:solid;border-bottom-width:0.5pt;color:#0000ff;font-family:'Times New Roman','Times','serif';font-size:12pt;text-decoration-line:underline;text-decoration-style:double;">Table Insert</u></p></td><td style="vertical-align:top;width:22.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">0</font></p></td></tr><tr><td style="vertical-align:top;width:77.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="color:#ff0000;font-family:'Times New Roman','Times','serif';font-size:12pt;text-decoration-line:line-through;text-decoration-style:solid;">Table Delete</font></p></td><td style="vertical-align:top;width:22.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">0</font></p></td></tr><tr><td style="vertical-align:top;width:77.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><u style="border-bottom-style:solid;border-bottom-width:0.5pt;color:#008000;font-family:'Times New Roman','Times','serif';font-size:12pt;text-decoration-line:underline;text-decoration-style:double;">Table moves to</u></p></td><td style="vertical-align:top;width:22.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">0</font></p></td></tr><tr><td style="vertical-align:top;width:77.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="color:#008000;font-family:'Times New Roman','Times','serif';font-size:12pt;text-decoration-line:line-through;text-decoration-style:solid;">Table moves from</font></p></td><td style="vertical-align:top;width:22.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">0</font></p></td></tr><tr><td style="vertical-align:top;width:77.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">Embedded Graphics (Visio, ChemDraw, Images etc.)</font></p></td><td style="vertical-align:top;width:22.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">0</font></p></td></tr><tr><td style="vertical-align:top;width:77.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">Embedded Excel </font></p></td><td style="vertical-align:top;width:22.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">0</font></p></td></tr><tr><td style="vertical-align:top;width:77.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">Format changes</font></p></td><td style="vertical-align:top;width:22.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">0</font></p></td></tr><tr><td style="vertical-align:top;width:77.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;">Total Changes: </b></p></td><td style="vertical-align:top;width:22.5%;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:0pt;padding:0pt 5.02pt 0pt 5.02pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;">10</font></p></td></tr></table></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>mmsi-20240515x8k001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 mmsi-20240515x8k001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !# 74# 2(  A$! Q$!_\0
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M/V@/AI874MM<>/?#T4\3%70ZC%E2.HZU#_PT7\+O^B@>'?\ P8Q_XU/MJ?\
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M1D]C7VOKWPK\)ZSX#N?"<V@V*:"ULT*6D<"JL0VX#)@?*PZAASGFN _9'^"
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M^6,>6^_^>GW7WU\CT(U:*PKKUZOMO9M.-T]&T[0?,M;OWG'6*4&D_>.T\%?
M7P-X&T\P6F@6E_>2_-=:IJD2W5Y=N?O/+*X+,2>?3T K@OC-\/M-^$&G7'Q3
M\"V$/A[5]$*7.JV6G((;;5K$,!/%-$N%+A"75\;@R]>:9\=/C+JVC?%CX?\
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MK],_V!_^3<M,_P"PA>_^CC7YF3$-/*0<@NQ!'?DU^F?[ _\ R;EIG_80O?\
MT<:\'+/X_P O\C]G\0/^1/'_ !Q_*1]$.ZQ(SNP1%!+,QP .Y-?E!^U-\:&^
M-?Q6O;^UE+^']-S8Z6O9HU/S2_61AG_="#M7VI^W7\4;WX>_!S^S=-+Q7OB2
M<Z:;E3@Q0["TN#ZLHV_1B>U?F[X;\.W_ (MU_3="TB#[1J6H3I:VT(Z%V.!G
MT ZD]@":Z,SKN4E0C\_T/"X RF%*E/-Z_FH^27Q2_3T3[D3Z/>1Z-#JSV[+I
MTUP]K'.?NO*BJSJ/7 =<_P"\*IU];_MJ_#;3_A'\+OA%X6TX!HK'[<)9\8,\
MS+"9)#[LQ)]A@=J^7_"'A34O'7BG2O#VD1>=J>IW"VT"GH"3RS>BJ,L3Z UY
M%6DZ53V;WT_%'Z?EF:4\QP7UY:0;EO\ RQDU=_)7?8IS:3>6^E6NI26[I8W4
MLD,$S#Y9'CV[P/7;O7/UK;^'/PXUWXK^*8O#OAR"&YU66)YDCGF$2E4 +?,>
M.]?0_P"W%X T_P"%WA[X3>%]*4_8M.L+R(2$<RONA+R'_:9B6/UKYP\$^.M=
M^''B"/7/#>H/I>JQQO$MRB(Y"L,,,,".<>E.=-4:O)/I:YG@L?4S7+OK>$LI
M2YN7FO;2346[:]$W8]D3]@[XQ,Z@Z/I: G&YM4CP/<X&:]S^)'P6?X$_L->(
M_#US>)?ZG-=07M[/""(_->XA&U,\[555&3UP3@9Q7S=_PV'\8_\ H>+G_P !
M+;_XW6+XQ_:1^)/Q \.W6A>(/%,^I:3=;3-;/;PH'VL&7E4!X90>O:NI5<-3
MC+D4KM-:V/FZN6\0XZM0>,JTE3ISC-J/,F^5WZI_+5>9YY8'&H6A])X__0A7
MO?[;GPHN/AW\9KW6$5GT?Q.SZC;RGHLW'GQD^H8AA[./2O ['_C_ +3_ *[Q
M_P#H0K]9/VF?@Y'\:_A/J.C1(O\ ;5J/MNERMP5N$!PN>P<%D/\ O9[4L-0]
MO2J);JS7XFN?YPLGS/ U*C_=SYXR\DW#7Y/7TN?F?\#O#7ACQC\5?#VB>,+R
M>QT.^N!"\ENP4O(?]7&S'[BNV%+#D9'3J/MC]O\ TFST+]G?0M-T^VCL["TU
MFU@@MX5VI&BPS!5 ] !7YWR1R02O'*CPS1L5=&&UD8'!!]""/S%=IXR^-GCO
MXAZ)%I'B7Q/>ZSIL4JS);W.S =00K9"@D@,>I[UG2KQITITVM7U.[,\FQ&.S
M/"8ZG5]RD[N+O]ZLMWL[]D3_   _Y+K\/?\ L.VG_HT5^BO[:G_)M'C/_<MO
M_2F*OSJ^ '/QU^'O_8=M/_1HK]%OVU/^39_&?^Y;?^E,5=V#_P!VK?UT/C>+
M/^2ARWUC_P"EH_+33?\ D)V/_7Q%_P"ABOV+^+'Q#MOA;X$U3Q#-";N>!1%9
MV2??N[IR$AA4=R[LH^F3VK\=--_Y"EC_ -?$7_H8K]4=2MW^)_[1R:==X&@?
M#^V@U'[,Q_X^=2N5<0R$?W8HE<C_ &I,]J672<8S4=W9+\?RW-..Z-.K7PLZ
MW\."G*7FDX*W_;S:C?I>_0ZCX(_#RX^'?@>.'59EN_$VIS/JFMWH_P"6][+\
MTF#_ '5X1?\ 905)\)/BE:?%K3_$.IZ<%.F6.LSZ7:S*<^>D2H#)]&<OCVQ6
M%^T'XEU#^Q=+\#>'IS!XH\93MIMO,GWK.U S=W7_ &SBSC_:=*R?V4O#]CX3
M\-^.M#TR'[/IVF>+]0M+>+.=L:"(*,^N!7LJ7+4C2ALOS_K5^I^4U*'M\%6S
M#$/]Y-IQ7]V]F_2_NQ[<LEV/:;N[AL+2:ZN94@MX$:2660X5$ R6)[  $UQ_
MP=^),/Q;\"6_BFUA\BQO+FY6U4]6ACG>-&/NRH&([9Q7'?'&]G\>^(="^$VF
M2.IUH?;_ !!/$<&VTB-AO3(Z-.^(A[%SVI_[),45O\#].@@18HH=1U.)(EZ1
MA;Z<!?;  %5[5RK\BVL_OT_*YA+ TZ65O$S_ (CE&R[1:GK_ -O..GDK]2QK
MWQ[NK#QMKWAK1OA_XC\4SZ(T*7=UIAMA$K2Q+(H_>2J?NMZ5S7C2[\<?'[2!
MX-7P%J7@KP_?31'6-7UZX@WBV217:*"*)W+2/M"[C@*"3R<5UNO_ +/NGZSX
MPUKQ):>+O%WAV]U=HGO(M$U-;>&1HXQ&AV^63G:H[U6_X9X;_HJ/Q'_\'J__
M !JLI1K2NI;:]MOSV/0HU\MH*G4HVC.*B[M3;4DE=VYN5VE=K2VUT,^$?_):
M/C9_V%-._P#2"*DUX_\ &5_@_P#[%34O_2FVKJ/AI\)=.^&$VN7%KJVLZW>Z
MS/'<7EYK=T+B9V2,1K\P5> H _"O%_VB/%^L^%_VBOA]:>&VMXO$.NZ1=:-9
M75VN^*T:6Y@+3LG\>Q8W(7N<4IWI4DY+[5_OE<K"J./S"4,.[KV3C=Z?#2Y6
MWV6C?H>T?&OQS8_#WX9Z[JEX?,E>W>ULK1>9+RZD!2&%%ZLS,0,#MD] :L?!
MSPG<^!/A3X0\/7AW7FF:5;6T^#D"18P& ]@<BN?\)? '2M%\0V?B3Q!K6L>.
MO$UF#]FU#7[@2):,?O-! H6.(GU"Y'K5?XV?$6\MQ'X!\'R+<_$#7XC% J?,
M-+MVXDOI\?<1 3M!Y9]H&>:V;<6ZM16Z)?UU9YT:<*T8Y?A)<UWS2DU9:*U^
MZC%7;;LW?96UQ/V3-8@\0Z+\1]3MB&M[OQOJDL;#H5)CP?QQFJ^FZY;V'[;>
MMZ;,ZI-J/@ZV: 'JQBN)"P'X.3^%3?LD>%[/P1X;\=^'=/W_ &+2O%EW9Q&1
MLN52& 98^IZ_C7'_ !*\$ZMXH_:0\2:QX7:-?&7AK0M*U+2?-?;'.WG72RVT
MA[+-'E,]CM/:N6\HT:;MK?\ SN>^X4*N98V#E:#A9-]+N'*WV5[7[*YZ!^T-
M,WA34_A_X_EC>72/"^KNVJ;%+&"TN(7@>? YQ&61CZ+N/:O7[*]M]2LX;NTG
MCNK6=!)%/"X=)%(R&5AP01W%<A\-OB;H7Q>\.33VB&*ZA)M=5T2_0"YL9L8>
M">,].XSC##D9%<I_PS!X:T^68>'->\5^#+"9B[Z9X>UJ2WM,GKMB.X1Y]$VB
MNI<UW4IZJ1\].-)PCA<:W3J4KI:733;=GJFFFVTU=-/I:[J?'35'^(>N:7\(
M='N3]HUC%UXCFMV^:QTE2"ZL1]UISB)1UP7/05[';VD6F:?';65ND<-O$(X+
M=/D154851Z#  KF/ GPU\+?"/1[U-&M5L8YF-S?ZC>3M+/<,!S)//(2S8&>6
M.!SC%<5'^U7X/O0\NFZ7XKUJQWLL6H:9X=N[BVG )&Z.14PZY!P1P:$U3;E5
M:3?Y#G2J8V$:& IRE3I[NV\I;MVNE=))*[T7>YY=X=^%GQ3O]4TUM?\ ".G0
M7UWXSM?$^L:\FM)*6CA<B.%(0F=D<6U%&[L3W->W?M)#/[/_ ,1?^P#>?^BF
MK'MOVHO"DNIZ;97.D^*M*.H7<5C#<:GX?N;:#S9&"(K2.H5<D@<FO2/&'A:R
M\;^%=7\/:EYO]GZI:R6=QY+;7\MU*MM.#@X-13IP]G*-.5[G;C,7BEB\/6QM
M'V:BTTDGLFKVNWLDDDK)*RL-\%Y/@W03_P!.%O\ ^BUK9KQZW_9JM+6".&'X
MB?$2.&-0B1IXB<*J@8  V] *Y[QQX?UW]GNRLO&.D>-?$/B'1K>^MK;5]%\2
M7@O%GMYIDBWPN5#1RH75A@X8 @BM/:3IQO*.B\SA6"P^+K<F'KWG)Z)Q:NWL
MKZZO9=+[M+4^@J***ZCP#Y:_X*+?\D.TK_L/0?\ HF:OSJLKVXTV\M[RTGDM
M;NWD6:&>%BKQNIRK*1T((!S7Z\?';X.:?\=/A[=>&;ZZDL',J7-K>1KN,$R9
MVL5XW#!8$9&0QY!YKX^;_@FSXNW''C/1",\$VLP_K7SN.PM:I6YX1NC]RX.X
MARO Y9]5QE50DI/1IZI^B9XCXH_:1\<^+M%O--N[K3[3^T%5-0OM-TZ*UO+]
M1R!-,@#,,@9QC/>M;6OVOOBKX@\%2^&+SQ&K64T/V>:ZCMU2[FC(P5:4<\C@
MD $\\\UZO_P[9\7_ /0YZ'_X"S?XT?\ #MGQ?_T.>A_^ LW^-<GL,9KH]?/_
M ()]+_:_"=HKFI^Z[KW'H^Z]WR7W+L>-P?M0_$"WT2.Q2]T_[;':_88]=.G1
M'5$@V[?+%SC=TXS][WSS5WPQ^U]\4_"'@N+PQI^OQ_88(O(M[FXMEENK>/&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+"BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>mmsi-20240515.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.6.2.5 -->
<!--Based on XBRL 2.1-->
<!--Created on: 5/21/2024 8:50:33 PM-->
<!--Modified on: 5/21/2024 8:50:33 PM-->
<xsd:schema targetNamespace="http://www.meritmedical.com/20240515" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:srt-roles="http://fasb.org/srt-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt="http://fasb.org/srt/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:attributeFormDefault="unqualified" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:cef="http://xbrl.sec.gov/cef/2024" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:mmsi="http://www.meritmedical.com/20240515" xmlns:rxp="http://xbrl.sec.gov/rxp/2024" xmlns:snj="http://xbrl.sec.gov/snj/2024" xmlns:us-gaap-ebp="http://fasb.org/us-gaap-ebp/2024">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="mmsi-20240515_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="mmsi-20240515_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>mmsi-20240515_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.6.2.5 -->
<!--Based on XBRL 2.1-->
<!--Created on: 5/21/2024 8:50:33 PM-->
<!--Modified on: 5/21/2024 8:50:33 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, State or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Fiscal Year End Date</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>mmsi-20240515_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  10.6.2.5 -->
<!--Based on XBRL 2.1-->
<!--Created on: 5/21/2024 8:50:33 PM-->
<!--Modified on: 5/21/2024 8:50:33 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="mmsi-20240515.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638519214339569924" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentType_638519214339569924" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638519214339579827" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_638519214339579827" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638519214339579827" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFileNumber_638519214339579827" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638519214339579827" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityRegistrantName_638519214339579827" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638519214339579827" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_638519214339579827" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638519214339579827" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_638519214339579827" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638519214339579827" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_638519214339579827" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638519214339579827" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_638519214339579827" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_638519214339579827" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_638519214339579827" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638519214339589812" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_638519214339589812" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638519214339589812" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CityAreaCode_638519214339589812" order="11" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638519214339589812" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_LocalPhoneNumber_638519214339589812" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_638519214339589812" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_WrittenCommunications_638519214339589812" order="13" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_638519214339589812" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SolicitingMaterial_638519214339589812" order="14" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_638519214339589812" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementTenderOffer_638519214339589812" order="15" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_638519214339589812" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_638519214339589812" order="16" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638519214339589812" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_Security12bTitle_638519214339589812" order="17" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638519214339589812" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_TradingSymbol_638519214339589812" order="18" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638519214339599799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SecurityExchangeName_638519214339599799" order="19" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638519214339599799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638519214339599799" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638519214339599799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCentralIndexKey_638519214339599799" order="21" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638519214339599799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentFlag_638519214339599799" order="22" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate_638519214339599799" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate_638519214339599799" order="23" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm139752493654064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 15, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 15,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-18592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MERIT MEDICAL SYSTEMS INC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-0447695<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1600 West Merit Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">South Jordan<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">253-1600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MMSI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000856982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M/UY_ 5!+ 0(4 Q0    ( (N&M5@'04UB@0   +$    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ BX:U6!,:8UKN
M*P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ BX:U6)E<G",0!@  G"<  !,              ( !S $  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " "+AK58LBS'PVL$  !&$0  &
M            @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ BX:U6)^@&_"Q @  X@P   T              ( !K@P  'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " "+AK58EXJ[',     3 @  "P
M    @ &*#P  7W)E;',O+G)E;'-02P$"% ,4    " "+AK58'#AEZC\!   \
M @  #P              @ %S$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ BX:U6"0>FZ*M    ^ $  !H              ( !WQ$  'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ BX:U6&60>9(9 0  SP,
M !,              ( !Q!(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/  D "0 ^ @  #A0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="mmsi-20240515x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  mmsi-20240515x8k.htm 9</Log>
  </Logs>
  <InputFiles>
    <File>mmsi-20240515.xsd</File>
    <File>mmsi-20240515_lab.xml</File>
    <File>mmsi-20240515_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="mmsi-20240515x8k.htm">mmsi-20240515x8k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mmsi-20240515x8k001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "mmsi-20240515x8k.htm": {
   "nsprefix": "mmsi",
   "nsuri": "http://www.meritmedical.com/20240515",
   "dts": {
    "schema": {
     "local": [
      "mmsi-20240515.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "mmsi-20240515_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mmsi-20240515_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "mmsi-20240515x8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2024": 4
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation",
     "longName": "00090 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mmsi-20240515x8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mmsi-20240515x8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document and Entity Information [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0000856982-24-000050-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000856982-24-000050-xbrl.zip
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M,QEDCTTBI:7L:))I8!?EV$31<(\VIZ(INPM/XT"T9F!T")0OG]I4-[]\ZM!
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M;6J;8.I,<HD,7Y,X2UGE"+1F ,XZ8-UDG D2>WQI8IX<NTXK70-M#YTI>%@
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MZ&*_2%+L<),7+8A+Z@?,!MP?V'I_U*,4_FLB0DAUX(/%X:<PJ33#^HJ:"3_
M$*GZV^0_4=@RX-MF0'%]#(@)OAUGE )<;'F4F?-QQE+#E,X&#?J4.C/Y$5GX
M017YN1E2?%S7B]'U1K C^NVV[+@V%$QV6:^;0S5M?2QZSOS-E]S?G)IPX*5&
M3;I#AVV$QY6O;4P2Q.--K/_PN"A WSB^-7*QKVVAH=MZ$5&D9I17)HI$89Y<
MDZTD6M9F:JP$%:R'8$EETO3<#@FP2GVIYWG\RDS7]0(LB',(A$CRZ>\IPL-
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MYMYY,Z_,O'7.^>/,V6?O]5GKL_;>G]G$&>(BP*RGK:L-D%T! #+2!1#G $V
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MW2^"KQ.!O+5I(D F!<;/AYH^9RZN#1F?N13]<Y<1)@*<B(PE[.K-IR\3'(@
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MXX79@59,4^-'7=Z8K7(9FC/C@2KHEJ*A"VU!S&I(8,AJM-CU,+&7-\VT=44
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M><BO.CU"!!HYW\@1@8@%?KS!4HB8T4S=-MW/=^^\)?;>M45=?GUF>0E=9Z+
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M:39E,-R;TIM'O%=^)/8QL6\1 >QN+B<1&%G/(P*+=]#+.O_9N9$21_-2,()
M4Y3U.F6Y7\S4Y13/3P3P3,>ER]6$"32+XVA!C4I18>.H3=;#XTU7QQ!SI8<W
M\N=9FEX_G#]M/QRTF01#]Z,SD6_17=.@6^;524RU^GX-6XU)O;'LSH$'2G<
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M8.4[Z3%*(?"2& !2DU@<YK#<MFY\[]&FER93CIWI=__X8$SL=\9=W:<TU![
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M?F'T00%-?P8<<J/T$T;<^$3&94JW5:*NXODJM*Z\SB-_IV(]%(3G^0);MTJ
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MS-&#V0*HI@BLJ-;IXS#H:,E\8,6#:-'*<"2M:/Z;_Y\/F#C[WP!02P,$%
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M"YOZS-W4+RMXZ?A^7]G-(O+<"/U;M[EI2KY-.@?9#F=@6G2YRDG[I""!X63
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M<O:B#[&@/M1DNMXF[?F9^$YN>^\](4&_-QO]+WDF9YN?R>=[!X?NM;\+P#K
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MV@[U<T]Q$:HFT;Q&EW+S]4'.[GIL!Z=L/<S9%ICG.&S/M\"\+3#O*P+S'HY
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M&-.<"U_"[HQU71?KEAE8J1U=84I2HT;&BJ]F,I!O<,:4"Y%"P?2D<Q\;W2=
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M-EQ+A3)E1IQW!HU!QE$D4[8#DT"A@+$9M 2/T&$B,+^6)@4&5/0F9&#3/N
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M4$L! A0#%     @ BX:U6)+(PF:5!0  ?CX  !4              ( !PP,
M &UM<VDM,C R-# U,35?;&%B+GAM;%!+ 0(4 Q0    ( (N&M5C,BRE1L@0
M ,HG   5              "  8L)  !M;7-I+3(P,C0P-3$U7W!R92YX;6Q0
M2P$"% ,4    " "+AK58]LEY%;,F  "[7P$ %               @ %P#@
M;6US:2TR,#(T,#4Q-7@X:RYH=&U02P$"% ,4    " "+AK58V_^+Q'<K   +
M+0  %P              @ %5-0  ;6US:2TR,#(T,#4Q-7@X:S P,2YJ<&=0
M2P$"% ,4    " "+AK58P$"38F8Y   NB $ %P              @ $!80
M;6US:2TR,#(T,#4Q-7AE>#%D,2YH=&U02P$"% ,4    " "+AK58:Z@=?+0M
M   /7P$ %P              @ &<F@  ;6US:2TR,#(T,#4Q-7AE>#-D,2YH
M=&U02P$"% ,4    " "+AK58\U4_H?,,  "M9@  &               @ &%
MR   ;6US:2TR,#(T,#4Q-7AE>#DY9#$N:'1M4$L%!@     (  @ ' (  *[5
$      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>mmsi-20240515x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mmsi-20240515.xsd" xlink:type="simple"/>
    <context id="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
        </entity>
        <period>
            <startDate>2024-05-15</startDate>
            <endDate>2024-05-15</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Tc_WZODp61qgke7ZyUdlBQ-5g_2_1">0000856982</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Tc_mc8a7Xc0JEG9eGYNe4lHcA_3_1">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Tc_MLqsBbKuPUW0kYP_2h30UA_4_1">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Hidden_FyixcHKUIUaBhKYYA5rylQ">MERIT MEDICAL SYSTEMS INC</dei:EntityRegistrantName>
    <dei:DocumentType
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Narr_C7zgHw-GMUie7iSN6METDw">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Narr_Ymz3qJnDPEKQbeEqmBBSdg">2024-05-15</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Tc_KrUERu-EWkuubGELXNmIaQ_1_0">UT</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Tc_l5ze_S_uiUihTWqv9TIqpw_1_2">0-18592</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Tc_vXVQrSJ3BUeuMbJyPhB5eA_1_4">87-0447695</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Tc_qsDn6iDGB0eHB5wiCivgnA_1_0">1600 West Merit Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Narr_-ViYoRdmV0O_n-l85UJs-w">South Jordan</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Narr_vVtSppVYjEmVmTmyHTLRgQ">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Tc_OsqEW2WKXUGAJqRtl4Y7fg_2_2">84095</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Narr_a9vDJzfmN0m9rQpdSQybug">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Narr_U4zipNAu00GXlMAFL1QIWw">253-1600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Narr_ejxHfFoQ1U2eegbL25gLGA">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Narr_l5l7FIusTEeQTNv0AhX9dw">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Narr_CTQN0i6owEGudlQG7C9T5Q">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Narr_JBCpdSETd0ygk5f9UT1X5g">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Tc_L_NzMt994UCPndKt8wkBVg_2_0">Common Stock, no par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Tc_bAmLuvQnX0SqNsZAV9g9iA_2_2">MMSI</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Narr_iah4uAQ0b06IxGAbIla6Jg">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_5_15_2024_To_5_15_2024_F8XtXMjc6katygJkE1h0ZQ"
      id="Narr_3ktRX-p9jk2Aihl_74Eb8w">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
